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Abstract 
The ocular surface presents a complex environment where the corneal epithelium has to interact 
with the tear film, the blink, and the many proteins, lipids, and signaling molecules that exist.  As a 
contact lens is placed into this environment, homeostasis may be unbalanced, and it may affect the 
overall patient satisfaction with lenses.  In order to study this effect at a cellular level, in vitro models 
offer the ability for cost-effective, tailored, and biologically-relevant methods to investigate material 
biocompatibility with the ocular surface.   
The development of an in vitro curved, stratified, human corneal epithelium has been instrumental 
in allowing for a more detailed investigation into biocompatibility at the ocular surface.  This 
advancement was followed by the creation of the tear replenishment system, which has incorporated 
the dynamic, fluidic effect of blinking and tear exchange, in combination with the in vitro epithelial 
model.  While these models have been used to probe cytotoxicity from contact lenses soaked in 
benzalkonium chloride, contact lens and solution interactions had yet to be studied using these 
models.   
Solution-induced corneal staining (SICS) is a clinical phenomenon that has led to the 
understanding that different lens and solution combinations interact differentially with the cornea.  
The first major goal of the thesis was to use in vitro models of the corneal epithelium to investigate 
SICS.  It was determined that cell death is likely not responsible for SICS, but cell death may be 
implicated in disruption of the epithelial barrier which could evoke microbial susceptibility. 
While the above models offer an advanced approach for the study of corneal biocompatibility, they 
lack incorporation of the innate immune system.  Before an inflammatory component may be 
incorporated into an in vitro model, an improved understanding of the role of ocular surface immune 
cells is required.  Hundreds of thousands of neutrophils are accumulated on the closed eye following 
sleep, and these neutrophils show a differential phenotype from blood-isolated neutrophils.  The 
second main goal of the thesis demonstrated that incubation of blood-isolated neutrophils under 
closed eye conditions is not responsible for the drastic change in inflammatory phenotype. 
Ultimately, this work has demonstrated the importance of in vitro models for the study of ocular 
phenomena and there is a great potential for the use of these models to better understand 
inflammation and biocompatibility of the cornea. 
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Chapter 1   
Introduction 
 
A little aqueous humour.  
 
 
 
Contact lenses are worn by over 140 million people worldwide [1], and while this constitutes a 
large market of wearers, contact lens adoption has a dropout rate of about 23% due to discomfort, 
dryness, and overall dissatisfaction with lenses [2].  There has been a lot of research to address this 
issue, and it may be attributed to lens design, multipurpose solution, or the innate biology that incites 
discomfort [3].  However, in terms of lenses, there has yet to be a material designed that is perfectly 
biocompatible:  a material that can perform vision correction without inciting discomfort, or correlate 
to increased infection or inflammation with use.  This thesis does not focus on comfort at all, but 
focuses on understanding the cellular basis of biocompatibility through the use of in vitro models.  
Through a better understanding of biocompatibility and inflammation at the ocular surface, we may in 
turn be able to design better lenses, which will provide fewer issues with biological integration, and 
will ultimately improve patient outcomes.   
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Our eyes provide us with arguably the most important sense of all:  vision.  As one of the most 
complex organs in the body, eyes have evolved to collect and transmit incoming light information to 
the brain.  To do so, there are many structures and functions of both tissues and cells in order to 
preserve the ability of the eye to do its job.  The eye is both offensive and defensive towards physical 
damage, infection, and inflammation.  However, the eye is not without weakness: the eye may be 
subject to disease and infection just like every other organ in the human body.  The normal 
homeostasis of the eye can become easily affected through its interaction with biomaterials and 
ophthalmic solutions, such as contact lenses and multipurpose disinfecting solutions, respectively.  
The purpose of this thesis was to develop cell culture models and conduct in vitro experiments in 
order to better evaluate biocompatibility at the ocular surface and to understand more about 
inflammation as it occurs in the eye. 
Biocompatibility of a material may be loosely defined as the ability of a material to interact with a 
tissue and perform a specific function without adversely affecting the biology of interaction [4].  
Therefore, a material that is biocompatible will seamlessly integrate into a biological environment 
without damage or stress of any cells without leading to inflammation or an immune response.  To 
evaluate biocompatibility at the ocular surface, the metrics may be widely varied from in vitro 
cytotoxicity, microscopy, or immunohistochemistry; to ex vivo sample collection and analysis; or to 
in vivo microscopy. 
In the development of new contact lenses and multipurpose solutions, in vitro studies are 
necessary to be undertaken, but are primarily used as a benchmark in order to demonstrate a lack of 
cytotoxicity.  However, in vitro studies can provide us with much more information if we understand 
the limitations and abilities of our models.  As an example, ocular surface health is examined in vivo 
solely through microscopic methods.  Therefore, we are only able to visually inspect the eye to 
investigate abnormalities, or use one of a few biological stains that are approved dyes for human 
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exposure.  This method only provides us with limited information on biocompatibility, and yet, it is 
considered the most important.  In vivo studies may be performed on animals, but in the case of 
rabbits and mice, the shape of the eye and the frequency of blink are completely different, which offer 
their own limitations in understanding.  However, with in vitro models, the capability exists to use 
human-derived tissues and study how they change at the cellular level.  In vitro models are often 
much more cost-effective, practical, and customizable.  If instead the focus shifts to what we can 
learn from in vitro models, instead of using them as a simple benchmark for cytotoxicity, we may 
solve many of the challenges that arise when products reach the clinical trial stage. 
Silicone hydrogels were first introduced commercially in 1998 [5].  With the introduction of 
silicone hydrogels came the advent of multipurpose disinfecting solutions (MPS).  MPS are used to 
clean and disinfect the lens in between lens wear.  MPS contain biocides that are used to kill 
microbes, but most of these biocides may also be cytotoxic to the human cornea [6].  These 
components may be easily adsorbed into the lens and the contact lens may thus act as a drug delivery 
device with a prolonged release and potentially cause undue damage to the ocular surface [7].  It was 
first reported in 2002 that different lens and solution combinations may affect the health of the 
cornea, and that the unique combinations were more important than the individual lens or solution in 
question [8].   
Our lab began by investigating these individual lens and solution interactions using monolayer 
cultures of human corneal epithelial cells.  Monolayer models allowed for the discovery that borate-
buffered solutions are more toxic than phosphate-buffered solutions [9] and for the investigation of 
lens and solution interactions using methodologies that are now commonplace [6].  The knowledge of 
monolayer cultures was then adapted to develop multilayered cultures [10].  In continuing to develop 
a comprehensive in vitro model to effectively mimic the in vivo situation, our lab also developed a 
tear replenishment system [11], which is a novel microfluidic device that effectively reproduces the 
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fluidic effect of blinking.  This thesis explores some of the parameters that affect lens and solution 
biocompatibility by using different combinations of products, different kinds of models, and different 
lens parameters to provide improved understanding of how lenses and solutions interact at the ocular 
surface. 
Assessment of in vivo lens and solution biocompatibility is generally performed using slit lamp 
biomicroscopy and a dye called sodium fluorescein.  It has been shown that each lens and solution 
combination presents a different level of sodium fluorescein staining.  This phenomenon is referred to 
as solution-induced corneal staining and is highlighted in Figure 1-1.  However, much about this 
phenomenon has yet to be understood.  Primarily, the mechanisms by which sodium fluorescein 
stains cells remained largely unknown for over 100 years.  This thesis aims to investigate whether cell 
death can be correlated with sodium fluorescein staining and if it is a potential mechanism at work.  
Further, this thesis aims to reproduce solution-induced corneal staining using our in vitro, curved, 
stratified model.  
 
Figure 1-1: Two eyes stained with sodium fluorescein.  The eye on the left shows no corneal 
staining, whereas the eye on the right shows classic micropunctate corneal staining.  Pictures 
courtesy of the Centre for Contact Lens Research at the University of Waterloo. 
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One component that was missing from our current in vitro studies is the effect of infection and 
inflammation on the ocular surface.  Infection, specifically in relation to contact lens wear, has been 
thoroughly investigated by other research groups [12-15] and is not the purpose of this thesis.  The 
inflammatory system is very complicated and is actively maintained through interactions between 
white blood cells, epithelium, and all of the many proteins and lipids that constitute both the tissues 
and fluids of the eye.  As the inflammatory system is in constant balance, this balance may be easily 
upset and may recruit inflammatory cells or cause the release of inflammatory mediators that could 
potentially damage the ocular surface.   
One inflammatory cell of the ocular surface that has thus far been neglected is the tear-film 
neutrophil.  When our eyes are closed for a prolonged period of time, the ocular surface becomes 
infiltrated with many polymorphonuclear neutrophils, and we call these cells tear-film neutrophils 
[16].  These cells were originally underestimated in their recruitment during sleep, and as a result, 
characterization was never fully performed on these cells.  In the past, whole-blood-isolated 
neutrophils have been used as a mimic for tear-film neutrophils [17], but it has been shown that these 
cells do not act in the same way.  This thesis tries to establish a tear-film neutrophil phenotype using 
blood-isolated neutrophils by incubating the cells under closed-eye conditions. 
This thesis begins with a background introduction to the eye, biocompatibility, and contact lenses 
in Chapter 2 and continues with a background on inflammation at the ocular surface in Chapter 3.  
Chapter 4 presents studies using monolayer and multilayered models to examine the mechanisms of 
fluorescein staining and lens and solution interaction.  Chapter 5 reports the work that has been done 
in trying to mimic the phenotype of tear-film neutrophils using blood-isolated neutrophils.  Finally, 
Chapter 6 and Chapter 7 present the conclusions and recommendations, respectively. 
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Chapter 2  
Ocular surface biocompatibility 
 
 
The plusses and minuses of  contact lens wear  
 
 
 
2.1 The Eye  
The eye is perhaps one of the most complex organs in the human body.  Its purpose is to obtain 
visual information from the outside world and transmit that information to the brain.  To do so, it is 
composed of many tissues with complex functions to collect, refract, and interpret incoming visual 
information.  A schematic of the eye is shown in Figure 2-1.  Incoming light first comes through the 
transparent cornea, followed by focusing through the lens, to arrive at the retina where light 
information is processed and transmitted to the brain via the optic nerve [18].  As a result, the cornea 
and lens must remain transparent as they account for the total refractory potential of the eye [18].  To 
detail the eye in terms of all of its many structures and functions requires many volumes of literature, 
so for the purpose of this thesis, the focus will be on the cornea, and specifically, on the ocular 
surface and the corneal epithelium. 
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Figure 2-1:  Anatomy of the eye:  cross-section. Adapted from a drawing by Ben Stone. 
2.2 The Cornea: Structure and Function 
The cornea is primarily important for refraction and acts as both a mechanical and physiological 
barrier to the internal ocular machinery.  More than two-thirds of the total refractive power of the eye 
is accounted for by the cornea alone [19].  The cornea is composed of six total layers, with three main 
cellular layers, as shown in Figure 2-2.  The three main cellular layers of the cornea are:  the 
endothelium, the stroma, and the epithelium.  The acellular Bowman’s layer lies between the stroma 
and the epithelium while Descemet’s layer lies between the stroma and endothelium.  It was recently 
reported that there is a pre-Descement’s layer, termed Dua’s layer [20], but this claim may be 
improperly founded as it may just be part of the stroma [21].  The endothelium is comprised of a 
single layer of cells that serve as a barrier to the aqueous humour and ensure appropriate water 
content of the corneal stroma [19].  The stroma primarily contributes to structure and mechanical 
strength through the use of collagen networks [19].  The corneal epithelium also contributes to the 
structure of the cornea, but is most important as the first line of defense against many types of injury, 
trauma, and infection [22-24].  The epithelium has also been shown to be the primary barrier against 
transcorneal permeation [25]. 
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Figure 2-2: Cross-section of the human cornea.  The breakdown of the layers of the human 
cornea is shown on the left.  Dua’s layer would be a pre-Descement’s layer that would sit 
between the stroma and Descemet’s membrane [20].  The three layers of the human corneal 
epithelium are shown on the right.  Histologic cross-section of the cornea obtained from [26]. 
From a lateral view, the ocular surface is composed of the conjunctiva, limbus, and cornea as 
illustrated in Figure 2-3.  The conjunctiva contributes to the structure of the eye, and is mainly 
important in the production of goblet cell-secreted mucins.  The conjunctiva is crucial in the immune 
response and does not have to remain transparent, which improves the diversity of its functionality.  
The limbus is identified as the region where the conjunctiva meets the cornea and is responsible for 
providing blood supply to the cornea.  This area also contains corneal and conjunctival stem cells 
[27]. 
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Figure 2-3:  Anatomy of the eye:  external.  © G. DeCesaris, 2012.  Used with permission. 
The corneal epithelium is composed of one cell type, but can be further broken down into three 
types of cells (Figure 2-2).  Columnar basal corneal epithelial cells sit as a monolayer on the 
basement membrane [28] which, as they differentiate, become more elongated and become wing cells 
[19].  Wing cells represent an intermediate stage of differentiation and are composed of two to three 
layers of cells [19].  The outmost layer of corneal epithelium is referred to as the superficial layer, 
where corneal epithelial cells are almost flat and contain desmosomes and tight junctions to impede 
passage of substances across the epithelium [19].  A more detailed outline of the function of the 
epithelium can be found in the next chapter. 
2.3 Contact Lenses 
Artificial lenses developed to be in contact with the ocular surface, i.e. contact lenses, have 
undergone a process of complicated development over the last 80 years.  Starting in the 1940s, 
contact lenses were made out of polymethylmethacrylate (PMMA) and this technology continued 
through until the 1980s, seeing notable improvements such as the incorporation of silicon or fluorine 
to improve oxygen transmissibility [29].  The 1980s saw the arrival of poly(2-hydroxyethyl 
methacrylate) (polyHEMA) lenses, which formed the basis of conventional hydrogel contact lens 
materials [29].  Conventional polyHEMA lenses were an improvement upon the rigid gas permeable 
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(RGP) lenses, and remain on the market today in spite of a relatively low oxygen transmissibility.  In 
the 1990s, silicone rubber was combined with conventional hydrogel technology to produce the first 
silicone hydrogel contact lenses [30].  Siloxane moieties were capable of greatly enhancing the 
oxygen delivery to the cornea [31].  However, this presented new challenges, as the silicone content 
decreased wettability and increased lipid interaction [30].  Therefore, surface modifications had to be 
developed to enhance the wettability of the polymer surface [30].  Examples of current conventional 
and silicone hydrogel lenses are shown in Table 2-1. 
 
Table 2-1:  Example of contact lenses and their material properties.  Adapted from [32-34] 
Proprietary 
Name 
Acuvue 2 Acuvue 
Oasys 
Biofinity Focus Night & 
Day 
Purevision 
Manufacturer Johnson and 
Johnson 
Johnson and 
Johnson 
Coopervision CIBA Vision Bausch & 
Lomb 
US Adopted 
Name 
Etafilcon A Senofilcon A Comfilcon A Lotrafilcon A Balafilcon A 
Hydrogel Type Conventional Silicone Silicone Silicone Silicone 
FDA Group IV V (I) V (I) V (I) V (III) 
Water Content 
(%) 
58 38 48 24 36 
Oxygen 
Transmissilibility 
(10-9) 
20 147 128 140 99 
Charge Charged Neutral Neutral Neutral Charged 
Principle 
Monomers 
HEMA + MA mPDMS + 
DMA + HEMA 
+ Siloxane 
Monomer 
+TEGDMA + 
PVP 
Undisclosed DMA + TRIS + 
Siloxane 
Monomer 
NVP + TPVC 
Surface 
Treatment 
None None, internal 
wetting agent 
None 25 nm plasma 
coating 
Plasma 
Oxidation 
Process 
DMA (N,N-dimethylacrylamide); HEMA (poly-2-hydroxyethyl methacrylate); mPDMS (monofunctional 
polydimethylsiloxane); NVP (N-vinyl pyrrolidone); PVP (polyvinyl pyrrolidone); TEGDMA (tetraethyleneglycol 
dimethacrylate); TPVC (tris-(trimethylsiloxysilyl) propylvinyl carbamate; TRIS (trimethylsiloxy silane). 
 
 
  11 
2.4 Contact Lens Solution 
Concurrent to the development of contact lenses was the development of contact lens solutions.  
Original contact lens solutions were primarily used for wetting and it was not until the 1970s that 
more sophisticated contact lens solutions were developed [35].  Contact lens solutions evolved into 
multipurpose disinfecting solutions (MPS) that are single solutions used to rinse, clean, and disinfect 
contact lenses.  MPS contain a mix of disinfectants, surfactants, chelating agents, demulcents 
(lubricant), buffers, that work together to provide antimicrobial efficacy [35].  A summary of 
solutions currently available on the market are shown in Table 2-2. 
Table 2-2:  Example of common multipurpose disinfecting contact lens solutions.  Adapted from 
[33,36] 
Manufacturer Brand 
(Abbreviation) 
Disinfecting 
Agent 
Buffer Other Reported Agents 
(Surfactants, Chelating 
Agents) 
Alcon Opti-Free 
Replenish (OFR) 
Polyquad® 
0.001% 
Aldox® 0.0005% 
Borate Citrate; poloxamine 
(Tetronic 1304); non-anoyl 
ethylene-diaminetriacetic 
acid (C9-E3DA), propylene 
glycol 
Bausch & Lomb renu Fresh (renu) PHMB 0.0001% Borate Sodium borate; 
hydroxyalkylphosphonate 
(HydranateTM); 0.1% EDTA; 
poloxamine (Tetronic 1107) 
CIBA Vision Clear Care (CC) H2O2 3% Phosphate Sodium chloride; 
phosphoric acid; poloxamer 
(Pluronic 17R4) 
 
2.5 Lens and Solution Interaction 
Due to the highly porous nature of hydrogel materials, contact lenses may have the potential to 
uptake significant quantities of the components of multipurpose disinfecting solutions [37].  Given 
that MPS contain strong antimicrobial agents, it is possible that this extended release will potentially 
compromise the health of the cornea [7].  Therefore, there is a balance between the bactericidal 
efficacy, where the solution kills pathogens during overnight disinfection, and its biocompatibility, or 
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lack of cytotoxicity, towards the corneal epithelium.  Kinetics of adsorption and desorption are known 
to be dependent on solution chemistry, as well as the lens composition and corresponding surface 
treatment [33,34,37]. 
2.6 Solution-Induced Corneal Staining 
This effect of lens and solution interaction has been observed in vivo through the use of sodium 
fluorescein staining [8].  Sodium fluorescein staining was originally developed in the late 1800’s as a 
method to observe changes in the overall health of the structure of the cornea.  A more detailed 
history of the use of sodium fluorescein staining can be found in Chapter 4.  In 2002, Jones et al. were 
the first to show that fluorescein staining could be observed in vivo following wear of specific lens 
and solution combinations [8].  This phenomenon has since been termed solution-induced corneal 
staining.  Since that time, many research groups have investigated lens and solution interaction both 
in vivo [36,38] and in vitro [33,39,40].   A more detailed discussion of in vitro work in lens and 
solution biocompatibility can be found later in this chapter. 
2.7 What is biocompatibility? 
Traditionally, biocompatibility is thought of by a simple definition:  “the ability of a material to 
perform without appropriate host response in a specific situation” [41].  This idea often gets conflated 
with cytotoxicity, which refers to the ability of a material to induce host cell death.  There are many 
situations where a biomaterial may not be cytotoxic, but may indeed poorly integrate with the host, or 
lose its desired function upon integration.  As a result, the following definition of biocompatibility 
was proposed [4]: 
“Biocompatibility refers to the ability of a biomaterial to perform its desired function with respect 
to a medical therapy, without eliciting any undesirable local or systemic effects in the recipient or 
beneficiary of that therapy, but generating the most appropriate beneficial cellular or tissue response 
in the specific situation, and optimising the clinically relevant performance of that therapy.” 
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In terms of development of new contact lenses or ophthalmic solutions, the FDA requires that 
researchers demonstrate that the material is not cytotoxic in vitro or in vivo through the agar overlay 
method or the ocular irritation assay (Draize test) [42].  The agar overlay method involves placing a 
contact lens on a bed of fibroblasts coated in agar, and measuring the radius of cell death extending 
from the contact lens [43].  Only recently has the FDA started to use this assay to investigate lens and 
solution interactions [42].  It is easy to assume that this in vitro method may be insufficient to show 
true biocompatibility of lens materials or of lens and solution interactions. 
2.8 In vitro Ocular Toxicity Testing 
The Draize test was developed as an ocular toxicity test in 1944 and involves the placement of test 
solutions on the eyes of living animals [44].  It became part of the United States Food and Drug 
Administration regulations in 1964 [45].  The Draize test has since come under much criticism in 
terms of its performance and reliability [45-47].  As the corneal epithelium represents the major 
barrier of the eye, many in vitro epithelial models have since been developed and proposed as 
alternatives to the in vivo Draize test.  Since the 1960s, monolayer cell cultures have been developed 
using primary and immortalized corneal epithelial cell lines of rabbit and canine origin; and starting 
in the 1990s, the use of human-derived cells has become more popular [48,49].  Immortalization is 
the process that allows for continuous proliferation and a prolonged lifespan, and it may be achieved 
through methods such as:  oncogenes, ectopic expression of the catalytic component of telomerase, or 
spontaneous establishment after serial cultivation of cells [45].  Cytotoxicity testing of ophthalmic 
solutions on corneal epithelial cells lines has been carried out on Madine-Darby Canine Kidney 
(MDCK) cells [50], human conjunctival epithelial cells [51], corneal-limbal epithelial cells [52], and 
human corneal epithelial cells (HCEC) [53-55].   
Concurrent to the development of better cell lines was the improved understanding of multilayered 
cultures and the importance of the air-liquid interface.  Multilayer models have since been grown 
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using many cell types and support membranes: immortalized human corneal epithelial cell lines CEPI 
17 CL4 and SV40 immortalized cells have been grown on polyester/polycarbonate Transwell cell 
culture inserts [56-59] and human corneal limbal epithelial cells have been grown on polyethylene 
terephthalate (PET) membranes [52].  Gipson [60] and Robertson [61] have also recently developed 
multilayered cultures.  Finally, tissue reconstruction for corneal transplantation has given rise to many 
different multilayered models with cells grown on human amniotic membrane or silk fibroin [62-64]. 
Commercially available models have also been developed, such as HCE by SkinEthic, EpiOcular 
by MatTek, and Clonetics by Lonza.  The most popular of these in vitro models is the SkinEthic 
Human Corneal Epithelial model that was developed in 2003 by Nguyen et al. [65].  There has since 
been much use of the SkinEthic model to investigate the toxicity potential of ophthalmic solutions 
[66-72] including a pre-validation study by Van Goethem et al. in 2005 where the SkinEthic model 
was shown to be a useful alternative for the in vivo Draize test [73]. 
The majority of these in vitro models have primarily been used for toxicity testing of different 
ophthalmic solutions and for drug permeation studies [73-76].  Recently, our research group focused 
on the development of a curved, stratified model of the human corneal epithelium to be used to 
specifically study the interaction of contact lenses with a multilayered model [10].  The model is 
curved in order to mimic the ocular surface and to facilitate proper contact lens wear.  This model has 
been used to demonstrate that it is sensitive to different concentrations of a known cytotoxic agent, 
benzalkonium chloride (BAK).  Our model has also shown that a PBS-soaked balafilcon A lens is 
biocompatible, which is a similar result from previous monolayer in vitro studies [9]. 
One of the drawbacks with both monolayer and multilayered in vitro models so far is that they 
have all been used under static conditions.  The eye is a very dynamic environment and the human 
eye holds approximately 7-30 µL of tears with a turnover rate of 0.5-2.2 µL/min [77-79].  
Spontaneous blinking happens at the rate of 6-15 times/min and helps to mechanically spread the tear 
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film evenly across the ocular surface and to remove any foreign objects in contact with the eye [79].  
Our laboratory recently developed a tear replenishment system (TRS) to mimic these effects in vitro 
[11].  Importantly, we showed that the TRS did not damage the curved, stratified, epithelium.  Our 
results also showed that there were mild differences in the cytotoxic responses of BAK-soaked lenses 
with and without tear replenishment [11].  It has been demonstrated in the intestine that three-
dimensional culture models in conjunction with dynamic systems are much more useful for in vitro 
investigation [80]. 
There has thus far been minimal work to understand lens and solution effects in vitro [6,39], and 
only a few studies focused on the response of stratified epithelium to MPS have been conducted [81-
83].  Chapter 4 presents the first study investigating lens and solution interactions using stratified 
human corneal epithelial cell cultures. 
2.9 Flow Cytometry 
Flow cytometry is a common analytical method used by our research group and methods in both 
Chapter 4 and Chapter 5 will demonstrate how it is used for practical purposes.  Flow cytometry 
consists of a microfluidic system whereby cells are analyzed for their relative size, granularity, and 
fluorescence intensity.  Cells travel single file to be illuminated by a laser beam, and based off of the 
diffracted (forward scatter) and reflected and refracted (side scatter) light, relative size and granularity 
can be obtained, respectively [84].  Fluorescent molecules within cells or fluorescent antibodies 
attached to cells may also be used to be excited and subsequently emit light.  Collection optics are 
employed to capture light of a specific wavelength and measure light intensity.  The events of each 
cell (forward scatter, side scatter, and fluorescent intensity) are counted and may be used as a 
quantitative metric.   
The BD FACSCalibur system used by our research group is capable of detecting three wavelength 
ranges, as shown in Table 2-3.   
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Table 2-3:  Description of the optics used by the BD FACSCalibur System. Filters used are 
either band pass (BP) or long pass (LP), meaning that they detect within a given wavelength 
range, or at longer wavelengths, respectively. 
Detector Filter Colour Fluorochrome 
FL1 BP 530/30 nm Green FITC 
FL2 BP 585/42 nm Yellow/Orange PE 
FL3 LP 670 nm Dark Red PerCP, PerCP-Cy5.5 
 
As a result, we may obtain a dot plot of side scatter versus forward scatter, which plots relative 
granularity versus relative size.  This is especially important in our blood experiments, given that 
different blood cells have different size and granularity.  This is highlighted in Figure 2-4. 
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Figure 2-4: Flow cytometry analysis of blood-isolated leukocytes.  The standard side scatter 
versus forward scatter plot is shown in a) which plots relative granularity versus relative size.  
b) plots side scatter versus fluorescence intensity of CD45, a pan-leukocyte marker.  All 
leukocytes stain with CD45, and they can be differentiated based upon relative granularity 
[84,85].  Blue cells are the granulocytes, which consist of neutrophils, basophils, and 
eosinophils; yellow cells are monocytes; and green cells are the lymphocytes.  c) shows a plot of 
side scatter versus fluorescence intensity for CD11b, a leukocyte activation marker, for only the 
granulocyte population.  Finally, d) shows a plot of counts versus fluorescence intensity of 
CD11b and this data may be quantitated and used for statistical analysis. 
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Chapter 3   
Inflammation and Immune Privilege at the Ocular 
Surface 
 
Check your immune privilege.  
 
 
 
Classically, immune privilege was considered as an “immunological ignorance” where tissue 
grafts could survive in regions of the body without immune rejection [86-88].  However, this 
definition has since broadened vastly as the cell and molecular environments that facilitate prolonged 
allograft survival are diverse and complex.  Modern immune privilege is perhaps confounded with the 
notion that immune privileged sites are able to resolve inflammation without provoking typical 
leukocyte-mediated immune responses.  As a result, an assumption may be made that immune 
privileged environments lack leukocytes, but in many cases, this is incorrect, and certain leukocytes 
may present an active tolerance. 
Several organs in the body are immune privileged, including the brain, the eye, and the testes [89]. 
The eye is especially of interest, given the fact that the ocular surface has to contend with pathogens 
on a daily basis.  It is also a unique organ given that many biomaterials interact with the eye, such as 
contact lenses, intraocular lenses, and glaucoma drainage devices.  In spite of all of the adversity that 
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the eye faces, its tissues can often remain uncompromised.  However, there are many cases where 
interaction with a biomaterial may exacerbate inflammation or be implicated in adverse events such 
as microbial keratitis [13] or posterior capsule opacification [90]. 
Overall, there has yet to be a complete understanding of the concert of immunological and 
inflammatory mechanisms of the eye, and further, how these mechanisms may affect interactions with 
biomaterials, such as contact lenses1.   
3.1 The Ocular Surface 
The eye is responsible for 70% of the sensory information that is taken to the brain [91] and as a 
result, many immune mechanisms are in place to resist compromise of the overall biological system.  
Innate immunity of the eye begins with its unique anatomy, specifically the physical barriers of the 
bony orbit, the lid wiper, and the lashes.  This defense continues to the ocular surface with the blink, 
tear film, and finally, to the epithelial cells of the cornea and conjunctiva.  In order to protect from 
pathogen invasion or damage, a complex environment exists in the tear film, complete with many 
proteins, mucins, and even commensal bacteria, which act harmoniously to protect from pathogens at 
the ocular surface [92,93].  The cornea also serves as a physical barrier to pathogens, but is unique in 
the fact that it must remain transparent in order to preserve vision [18].  In preserving vision, the 
cornea is avascular and obtains its blood supply from the peripheral limbus [94].  The paramount 
structure in place is the corneal epithelium, which is rich with receptors and mechanisms to preserve 
vision by maintaining integrity and combatting local infection and inflammation.  This delicate 
concert of structure and function is also aided by a ménage of inflammatory cells that patrol the 
ocular surface as part of both the innate and adaptive immune systems.  As this system is in a constant 
effort to maintain balance, it is possible that this environment can become compromised either 
                                                     
1 The above three paragraphs were co-written with Robert Pintwala as part of the introduction to a review paper 
on immune privilege of the anterior eye, yet to be submitted. 
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through auto-immune disorders or through microbial infection.  With the introduction of a biomaterial 
into this environment, specifically a contact lens, it remains to be well understood how the machinery 
of the ocular surface is impacted. 
3.2 Non-Leukocyte Mediated Innate Immunity 
3.2.1 Proteins in the tear fluid 
To date, over 1500 proteins have been found in human tear fluid [95].  Given the significant 
advances in mass spectrometry, we are now able to obtain very detailed resolution of the proteins that 
exist at the ocular surface [95,96].  Historically, the major proteins that have been of interest at the 
ocular surface include lactoferrin, lysozyme, lipocalin, and secretory immunoglobulin A (IgA), as 
these proteins represent the major portion of the tear proteome [95].  A summary of their properties 
may be found in Table 3-1. 
 
Table 3-1: Description of main proteins of the tear film.  Adapted from [92,93,97]. 
Name % in Tear 
Fluid 
Description Origin 
lysozyme 20-30% - destabilizes cell wall of pathogens lacrimal gland 
lactoferrin 20-30% - interferes with ability of pathogens to uptake iron lacrimal gland 
tear lipocalin 25% - interferes with ability of pathogens to uptake iron 
- protect ocular surface from proteolytic damage 
lacrimal gland 
secretory IgA diurnal 
variation 
- promotes clearance of pathogens 
- resists bacterial adherence 
plasma cells 
lacrimal gland 
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Among those 1500 proteins are many other proteins, including many anti-microbials and anti-
virals.  Some examples of anti-viral proteins in the tear fluid are lactate dehydrogenase, complement 
proteins, amylase, peroxidase, and interferons alpha and beta [98]. 
Perhaps most important in inflammation is the class of small proteins known as cytokines: specific 
proteins that are responsible for inflammatory and immune cell activation and recruitment, and are 
produced by all of the ocular surface cells such as the corneal and conjunctival epithelial cells, 
stromal cells, and resident antigen-presenting cells [99].  A subset of cytokines includes chemokines, 
which are usually used for recruitment and movement of inflammatory cells.  Another relevant class 
of proteins in the tear film is growth factors, which induce many processes including re-
epithelialization and neovascularization, and play an important role in corneal homeostasis [100].  It 
is important to note that these small molecules control the majority of cell-to-cell signaling and do not 
necessarily have to be in abundant quantities in order to have a significant effect on the inflammatory 
cascades present in the eye. 
The tear film also contains a layer of mucins that are produced primarily by goblet cells in the 
conjunctiva [101].  Mucins are highly glycosylated proteins that are both secreted and membrane-
associated [102,103].  They function to maintain tear stability and hydration of the ocular surface 
while providing a barrier to pathogens and particulates. 
3.2.2 Lipid Mediators 
While proteins have many functions within the body, lipids serve as an integral part of regulatory 
circuits in terms of initiating, perpetuating, and ultimately resolving2 leukocyte-mediated 
inflammation [104,105].  A common lipid mediator family are the eicosanoids, which are derived 
from the polyunsaturated fatty acid arachidonic acid.  Arachidonic acid is primarily catalyzed to form 
                                                     
2 Resolution is a process of removal of neutrophils from sites of acute inflammation.  This is particularly 
important as prolonged neutrophil residence (and stimulation) can result in tissue injury and even in systemic 
disease.  
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lipid mediators by one of two enzyme pathways:  the cyclooxygenases or the lipoxygenases [106].  
These lipid mediators are formed in response to stress, injury, or inflammatory stimuli. 
Lipid mediators are particularly important at the ocular surface as they interact with the heme 
oxygenase enzyme system.  Heme oxygenases are responsible for the catalysis of heme in order to 
produce antioxidants and carbon monoxide, which have essential cytoprotective functions [106].  The 
lipid circuits generate feedback in combination with the heme oxygenase system in order to amplify 
anti-inflammatory efforts [104,106].  Lipid mediators are also instrumental in wound healing 
responses in mice, and these circuits have a differential, sex-specific response [107]. 
3.2.3 Commensal bacteria 
In normal, healthy, human corneas, there can often be found a population of bacteria that live 
either on the eyelid or the ocular surface.  There does, however, seem to be a very large variation in 
the strains, types, and prevalence of ocular flora that has been identified depending both on the 
experimental techniques and the location where the studies were performed [12].  In spite of a 
constant or usual microbial burden at the ocular surface, the immune system has been able to develop 
mechanisms that regulate microbial inflammation.  It has been suggested that the population of 
commensal bacteria is usually polyclonal, meaning that the ocular flora exists in a balanced state.  
However, when the population of bacteria becomes monoclonal, implying that one strain dominates, 
this is more likely when infection occurs, or conversely, during infection, one strain dominates the 
ocular surface [108].  Dysregulation of the immune system may lead to chronic blepharitis, 
conjunctivitis, and keratitis [108].  
3.2.4 Epithelium 
The human cornea is composed of three main cellular layers:  the epithelium, the stroma, and the 
endothelium.  The outermost of these layers is the epithelium, and its primary responsibility is to 
prevent pathogen invasion.  As a result, the epithelium has many features such as tight junctions, 
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defensins, toll-like receptors, and ligand receptors within its arsenal in order to combat infection and 
inflammation.   
Tight junctions are protein complexes in the superficial epithelial layer that serve as a physical 
barrier to pathogens.  The tight junction complexes are composed of transmembrane proteins claudin 
and occludin, proteins of the membrane-associated guanylate kinase homologue family (ZO-1, ZO-2, 
and ZO-3), and actin filaments [109].   
While the superficial epithelium serves as a physical barrier, it can also serve as a metabolic 
barrier.  In order to maintain its immune privileged state, the corneal epithelium must also resist 
viruses.  While there are many anti-viral mechanisms in place, perhaps one of the most interesting 
features is the turnover of the corneal epithelium.  The outermost superficial corneal epithelial layer is 
terminally differentiated, and this creates a metabolic barrier, as viruses depend on replication and 
dissemination in metabolically active cells [98]. 
Defensins are a group of antimicrobial peptides at the ocular surface that can perform varied 
functions, primarily to disrupt microbial membranes [110].  The human corneal epithelium features 
many isoforms of human beta defensins and can produce inflammatory cytokines such as IL-1α, IL-
1β, TNFα, IL-6, and IL-8 [108].  
Toll-like receptors are expressed on many cell types, including the corneal epithelium, stroma, 
endothelium, antigen presenting cells, and lymphocytes [111].  Toll-like receptors are pattern 
recognition receptors that recognize pathogens via the pathogen associated molecular patterns 
(PAMPs) found on bacteria, viruses, fungi, and protozoa [108,111].  So far, there have been 10 TLRs 
identified, and all of these are expressed on ocular surface epithelia, though TLRs 7 and 8 are more 
rarely found [108,111].  Briefly, activation of the TLRs by PAMPs initiates innate and acquired 
immune responses through the release of cytokines and chemokines that recruit neutrophils and 
lymphocytes [111]. 
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While TLRs are known for binding exogenous PAMPs, it is also possible that TLR activation may 
be caused by endogenous ligands, referred to as danger/damage associated molecular patterns 
(DAMPs).  These DAMPs are often cytosolic proteins that are released following injury or necrosis 
[111,112].  Thus, the TLRs may act as a surveillance system for tissue injury as well as for infection.  
However, it is possible that endogenous activation of TLRs could lead to autoimmune disorders 
[112].  As TLRs may be triggered by both exogenous and endogenous ligands, the signaling 
pathways may be very complex and have been the subject of several reviews [108,111,113] 
3.3 Leukocyte Mediated Innate Immunity 
In response to infection, the cornea responds similarly to the rest of the body with the innate 
immune response of PMNs, natural killer cells, and macrophages, along with the adaptive immune 
response facilitated by dendritic cells and T cells [114].  Other research focuses on the subject of the 
detailed inflammatory response to wound healing in the cornea [115-117]. 
Of particular interest is how leukocytes aid in the maintenance of immune homeostasis at the 
cornea.  Immune privilege easily conjures an image where inflammatory processes do not occur 
because inflammatory cells do not exist; however, it has since been shown that certain leukocytes 
may have developed an immune tolerance or ignorance [89].  The normal, healthy human cornea 
contains a resident population of antigen-presenting cells; namely, Langerhans cells, dendritic cells, 
and macrophages [118].  In a closed-eye environment (during sleep), large numbers of 
polymorphonuclear neutrophils (PMNs) are recruited to the ocular surface in a non-inflammatory 
state [92]. 
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3.3.1 Antigen3-Presenting Cells 
Within the cornea, there is a resident population of dendritic cells [118].  Around the periphery, 
these cells are major histocompatibility complex II (MHC II) positive, and can thus be thought of as 
mature dendritic cells.  However, the central stroma contains immature dendritic cells that are MHC 
II negative.  The maturity of a dendritic cell can be equated with how well the dendritic cell is able to 
recruit T-lymphocytes, where immature dendritic cells are strong at antigen capture, but weak at T-
cell activation, and mature dendritic cells are weak at antigen capture, but strong at T-cell activation 
[118]. 
Langerhans cells are similar in structure and function to a dendritic cell, but are unique in that they 
are the only MHC II+ cells that exist in the corneal epithelium under non-inflamed conditions.  These 
cells have been found in both the centre and the periphery of the epithelium and reside at the basal 
layer of epithelium [118].  Macrophages are the final type of antigen-presenting cell found in the 
cornea, and it has only been more recently that these cells have been discovered in the central stroma 
of mice [119].  It has been shown that resident macrophages are primarily responsible for 
neovascularization of the cornea [120]. 
Overall, it remains largely unknown how these antigen-presenting cells operate in a non-
inflammatory state.  It is also possible that these cells are meant to be quiescent in a non-
inflammatory state, given that their role is to present antigens.  However, without antigen 
presentation, it also remains a mystery as to how dendritic cells, macrophages, and Langerhans cells 
may be recruited to the cornea and ocular tissues [98]. 
                                                     
3 An antigen is any molecule that promotes the formation of antibodies, and thus, initiates an immune 
response.  
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3.3.2 Tear-Film Neutrophils 
Neutrophils are the most prominent of all immune cells in the body and are the first responders to 
inflammation.  Neutrophils are known by their banded or multi-lobed nuclear structure, which is why 
they are also called polymorphonuclear leukocytes (PMNs) [121].  They contain an arsenal of 
inflammatory mediators, bactericidal agents, proteolytic enzymes and oxidative products with which 
to combat infection and inflammation [122].  They also have a short half-life and a high turnover rate 
[121].   
When the eye is closed for a prolonged period of time, hundreds of thousands of PMNs are 
recruited to the ocular surface.  This constitutes a very large population of PMNs, so much so that the 
concentration of PMNs in the closed-eye tear film can be equated to approximately 4 times the 
concentration of PMNs in the blood [16].  This influx of neutrophils that are collected immediately 
upon waking occurs in normal, healthy, individuals as a part of immune homeostasis, and will 
hereafter be referred to as tear-film neutrophils. 
The tear-film neturophils were first observed by Wilson et al. in 1989 [123].  In the late 90s’ and 
early 2000s’, Sack et al. investigated tear-film neutrophil recruitment, studying the variations in 
chemotactic and inflammatory mediators in the closed-eye environment, and the time course of PMN 
recruitment [92,124,125].  The result of the studies was that the tear-film neutrophils existed to 
phagocytose potential pathogens.  No functional study was performed, and only cell numbers were 
recorded. 
In the first study to characterize their phenotype [126], tear-film neutrophils demonstrate a 
significant difference from the classical inflammatory phenotype described above.  In this study, tear-
film neutrophils were tested in terms of their ability to activate.  Neutrophils commonly exist in one 
of three inflammatory phenotypes:  quiescent, primed, or activated [127].  Quiescent neutrophils are 
non-inflammatory, primed neutrophils have encountered a stimulus or environment that have changed 
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their ability to activate, and activated cells are those that release inflammatory mediators and 
oxidative products.  Neutrophils that have been primed prior to activation mount a much larger 
inflammatory response as compared to neutrophils that were not primed.  A common stimuli may be 
bacterial endotoxin, or lipopolysaccharide (LPS), which are fragments of cell walls from gram 
positive bacteria [128]. 
To investigate changes in neutrophil phenotype, it is common to examine expression of membrane 
receptors on neutrophils, which become increased (upregulated) or decreased 
(downregulated/internalized) depending on their function.  A summary of important neutrophil 
membrane receptors is highlighted in Table 3-2. 
 
Table 3-2:  List of common antibodies used for investigation of neutrophil membrane receptor 
expression. 
Cluster of 
Differentiation 
(CD) or Antibody 
Leukocyte (Antigen) Function Assessed 
CD11b Important in cell adhesion and leukocyte activation, also known as the macrophage-1 
antigen (Mac-1), binds to fibrinogen and iC3b 
CD14 Binds lipopolysaccharide and pathogen-associated molecular patterns; typically used to 
differentiate neutrophils (CD14-) from monocytes (CD14+) [129,130] 
CD16 FCγRIII receptor, shedding is implicated in cell death and may lead to resolution 
through nonphlogistic4 phagocytosis by macrophages [131,132] 
CD33 Myeloid antigen, expressed on immature granulocytes 
CD45 Pan-leukocyte marker 
CD54 Intracellular adhesion molecule (ICAM-1), upregulated on activated cells 
CD62L L-selectin, cellular adhesion molecule that is shed upon neutrophil transmigration  
CD66b Degranulation membrane marker, released upon activation 
C3aR Receptor for C3a, part of complement activation 
 
                                                     
4 Nonphlogistic phagocytosis refers to phagocytosis without the release of inflammatory cytokines. 
  28 
The tear-film neutrophils from [16] were incubated with one of three inflammatory stimuli: 
lipopolysaccharide (LPS), bacterial endotoxin from the outer cell membrane of gram-negative 
bacteria; phorbol myristate acetate (PMA), a potent synthetic chemical and activator of protein kinase 
C; and N-formyl methionyl-leucyl-phenylalanine (fMLP), a chemotactic peptide.  Following 
stimulus, tear-film neutrophils showed a lack of upregulation of inflammatory markers investigated: 
degranulation (CD66b), macrophage-1 antigen (CD11b), and intracellular adhesion molecule-1 
(CD54).  This was in contrast to the response observed with blood-isolated neutrophils, which under 
similar experimental conditions were able to mount the expected inflammatory response.  Given these 
results, the role that tear-film neutrophils play and what effects they have on the ocular surface remain 
to be fully characterized. 
Like the resident antigen presenting cells in the cornea, it is also not well understood how the tear-
film PMNs are recruited to the ocular surface and where they come from.  In response to 
inflammation, PMNs are recruited from limbal vasculature through the stroma [133].  This 
recruitment is complicated and requires extensive integrin signaling, selectin expression, and 
chemokine regulation that make it unlikely to be the source of hundreds of thousands of quiescent 
neutrophils. 
Similar to toll-like receptor activation and commensal bacteria, neutrophils may also become 
systemically dysregulated [104].  Dysregulation of any of these processes may lead or contribute to 
epithelial, stromal, microbial, or fungal keratitis, allergic conjunctivitis, or autoimmune diseases such 
as dry eye or even age-related macular degeneration [98,104,111]. 
3.3.3 NETosis 
Aside from the standard degranulation process that occurs in neutrophils, whereby neutrophils 
release toxic reactive oxygen species (ROS) and antimicrobial granular proteins [134], neutrophils are 
also capable of creating neutrophil extracellular traps (NETs).  This process of neutrophil cell death is 
  29 
distinct from apoptosis or necrosis [135].  NETs contain decondensed chromatin fibres, histones, and 
antimicrobial proteins [136].  These NETs serve to combat infection and inflammation through a 
process termed NETosis.  However, improper regulation and clearance of NETs may have deleterious 
effects such as increased inflammation and this has been implicated in autoimmune disease 
pathogenesis [137].  NET components have been identified on the ocular surface and it has been 
suggested that dry eye disease pathogenesis may be affected by the dysregulation of NET clearance 
[138].  It has yet to be determined if tear-film neutrophils are capable of undergoing NETosis. 
Returning to the concept of immune privilege, the main goal of the ocular surface machinery, ie. 
the proteins, epithelial cells, and inflammatory cells of the eye, is to preserve vision.  A classical 
inflammatory response by neutrophils at the cornea would result in many cytolytic compounds being 
released on the cornea and would almost certainly compromise vision.  It is possible that our immune 
system has evolved a special kind of phenotype for the tear-film neutrophil so that the ocular surface 
is able to combat inflammation without mounting a full inflammatory response.  But how does this 
change in the presence of a biomaterial? 
3.4 Biomaterials Interactions 
The most common biomaterial that interacts with the ocular surface is the contact lens.  Contact 
lenses are hydrogel polymers that are typically made from poly(2-hydroxyethylmethacrylate) 
(HEMA) or incorporate silicone rubber to create silicone hydrogels [29].  However, all of these 
polymers have various surface treatments or monomers (wetting agents) added in order to increase 
oxygen transmissibility to reduce corneal hypoxia [30]. 
In a classic model of biomaterial implantation into the body, the very first consideration that needs 
to be made is of protein adsorption to the biomaterial surface.  Typical proteins that interact with 
biomaterials are albumin and fibrinogen, two main proteins in the blood.  However, contact lenses 
have to interact with all of the 1543 proteins present in the tear film [95].  Protein adsorption depends 
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on lens material, surface charge, and the concentration, charge, and structure of the protein.  Many 
studies have been performed to characterize protein adsorption on contact lenses, and to develop 
assays to image protein content both in vitro and in vivo (for a complete review of these studies, see 
[139]).  Proteomics have also been used to investigate protein deposits following contact lens wear 
[140,141].  In spite of the wealth of research that has been conducted, there has yet to be any 
correlation between lens deposits and observable adverse effects on the cornea [141].  
Contact lenses may greatly affect patient comfort, with roughly 23% of contact lens wearers 
discontinuing wear as a result of discomfort and dryness [2].  Decreased comfort could be a result of 
lens design, multipurpose solution, or changes in the ocular biology [3].  It has been shown that 
contact lens wear affects regular corneal homeostasis by impacting corneal epithelial cell turnover, 
the rate of cell exfoliation, and may result in corneal thinning [142].   
As mentioned above, the eye may often be subject to commensal bacteria, and yet it is rarely 
compromised enough to result in microbial infection.  Contact lens wearers, particularly while 
sleeping with a contact lens, are at an increased risk of microbial keratitis [13,143,144].  Between 
1991 and 2006, a twofold increase in the occurrence of corneal infiltrative events (CIE)5 [145] was 
also observed with silicone hydrogel lenses as compared to conventional hydrogels [146].  However, 
silicone hydrogel contact lens wear comes in two different modalities; namely daily wear, where 
lenses are replaced daily; and extended wear, where lenses are worn continuously for up to a month.  
It was recently reported that a daily wear modality could significantly reduce CIE as compared to 
extended wear use [147], implying that the practical aspects of lens wear could also impact 
biocompatibility. 
                                                     
5 Corneal infiltrative events are clinically observed signs of inflammation that often correlate with patient 
symptoms of redness, irritation, or pain [60].  
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Most of the work that has been done on immune cell interaction with contact lenses has focused 
on the role of PMNs in ocular infection.  Work that has been done so far has focused on the use of 
blood-isolated neutrophils, and these neutrophils may exacerbate infection as dead PMNs may 
promote biofilm formation on silicone hydrogel contact lenses [148,149].   Further, some strains of 
bacteria may not induce a respiratory burst in blood-isolated PMN, at all [149], though all strains 
affect cytokine release from blood-isolated PMNs [150].  It remains to be determined if tear-film 
neutrophils act in a similar capacity. 
A brief investigation on tear-film neutrophils collected from contact lens wearers has shown a 
reduced expression of degranulation markers CD66b and CD33 when compared to non-lens wearers 
[151].  The same investigation also indicated that the tear-film neutrophils collected directly from the 
contact lens had a different phenotype from the tear-film neutrophils collected from the ocular 
surface, suggesting that tear-film neutrophils somehow respond to changes in their environment, such 
as the introduction of a silicone hydrogel contact lens.  Internalization of the C3a receptor on tear-film 
neutrophils was also observed following overnight lens wear [152].  A pilot study by Sindt et al. 
showed that dendritic cell densities in the cornea are also affected by both contact lens wear and by 
specific multipurpose disinfecting solutions used, though the implications of this also have to be 
elucidated [153]. 
While these results have yet to be fully interpreted in the context of overall ocular inflammation, it 
can be demonstrated that a contact lens biomaterial significantly impacts the homeostasis of the eye in 
terms of its ability to preserve vision.  Contact lens and materials science researchers have been 
consistently trying to develop contact lenses with increased oxygen permeability, and while their 
goals have been achieved, the overall biocompatibility, as defined by optimal comfort and an absence 
of inflammation or infection, has yet to show any improvement.  Given our lack of understanding of 
immune privilege at the ocular surface, more thorough investigations into the inflammatory 
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mechanisms of the ocular surface will help us in solving contact lens related infection, discomfort, 
and inflammation. 
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Chapter 4  
Reproduction of micropunctate corneal staining in 
vitro 
 
Discovering that twinkle in your eye.  
 
 
 
4.1 Introduction 
Staining of the cornea following topical instillation of sodium fluorescein, referred to as 
fluorescein staining or corneal staining, was originally developed in the late 1800s as a method to 
observe changes in the morphology of the cornea, and specifically for the visual inspection of corneal 
epithelial abrasions in rabbits [154], followed by corneal epithelial lesions in humans [155,156]. 
Following sodium fluorescein instillation, clinicians evaluate the cornea using a slit-lamp 
biomicroscope and a cobalt blue light to induce fluorescence of the dye. 
Sodium fluorescein has been used for the clinical evaluation of corneal epithelial abrasions or 
defects, tear break-up time, contact lens fitting, tear volume and clearance, aqueous humour flow and 
leakage, and corneal epithelial and endothelial permeability [157].  Sodium fluorescein is used to 
diagnose the cornea in response to chemical injury, mechanical insult, and dehydration [158].  It has 
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also been noted that sodium fluorescein staining occurs regularly in healthy individuals [159-162] as 
well as in patients with dry eye [163,164]. 
In 2002, Jones et al. observed that corneal staining may also arise as a result of an interaction 
between a contact lens and a multipurpose disinfecting solution (MPS) [8], a phenomenon that has 
since been termed solution-induced corneal staining (SICS).  Andrasko et al. [36] and the IER 
staining matrix [38] have since dedicated much time and effort to catalogue the different responses as 
a result of all different lens and MPS combinations.  Long before solution-induced corneal staining 
even existed, staining as a result of contact lens wear was stated to be a “danger signal” [159].  As a 
result, solution-induced corneal staining generally has a negative connotation and has even been 
plainly described as a manifestation of MPS cytotoxicity [165].  Solution-induced corneal staining is 
currently considered the in vivo metric of contact lens and MPS biocompatibility [7]. 
However, the overall significance of this phenomenon has been a topic of much debate [161,166-
169], literally [170,171].  Without going into detail on the many arguments of the clinical 
manifestations of sodium fluorescein staining, it may suffice to say that a lot of argument on the 
impact of solution-induced corneal staining arises from a lack of knowledge on the fundamental 
biological processes at play.  Specifically, the mechanisms of sodium fluorescein staining (let alone 
SICS) have yet to be fully elucidated. 
Historically, sodium fluorescein staining was thought to occur under one of three different 
mechanisms: ingress, pooling, or dead cells [172].  Originally, given its ability to diffuse through the 
cornea, sodium fluorescein was presumed to be caught in the ingress around cells from a lack of tight 
junctions [156,157,173].  It was also postulated that fluorescein would pool in areas of epithelial 
defect as a result of shed cells [159].  Another mechanism postulated was that staining would occur in 
cells that are dead, dying, or desquamating as part of natural epithelial turnover [160,174]. 
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Since, these historical mechanisms have mostly been disproven.  Given that rinsing of the ocular 
surface does not change the overall pattern of fluorescein staining (or remove it), staining as a result 
of ingress and pooling is unlikely [175,176].  Further, micropunctate spots may be removed by 
impression cytology, which is not physically possible with any pooling mechanism [163,177].  
Finally, it has been shown on numerous occasions that staining is intracellular [157,163,177] and that 
fluorescein-stained cells are alive [7,158,176,178,179]. However, while they are alive, it may be 
possible that the fluorescein-stained cells are undergoing some form of apoptosis [7,178,179]. 
Many cell types within the human body readily uptake sodium fluorescein [180] or rose bengal 
[181], and yet, the corneal epithelium does not consistently uptake either of these molecules.  This 
implies that the cornea has a mechanism that blocks the entry into the cells.  Diffusion is not alone 
responsible for fluorescein transport given that wing cells have been found to uptake sodium 
fluorescein in areas where superficial cells did not stain with the dye [163].  Recently, Bakkar et al. 
proved that fluorescein transport is mediated by active transport as there was a temperature 
dependence on uptake and release of sodium fluorescein [158].  Fluorescein transport may occur as 
an active process across tissues via monocarboxylic acid cotransporters [182,183].  These same 
transporters have been found in the corneal epithelium [184].   
Lastly, sodium fluorescein may also be bound to or blocked by other components at the ocular 
surface such as mucins or PHMB [185], a molecule commonly found in ophthalmic solutions.  
Mucins are highly glycosylated glycoproteins that are both secreted and membrane-associated 
[102,103].  Together, they function to maintain tear stability and hydration of the ocular surface while 
providing a barrier to pathogens and particulates.  Mucin defects could therefore increase sodium 
fluorescein permeability [83,163,177,181] and increased mucin mRNA expression has been 
previously correlated with increases in sodium fluorescein staining in atopic disease [186]. 
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This current study presents an investigation of the mechanism of solution-induced corneal staining 
through the use of monolayer and multilayer in vitro human corneal epithelial models.  Specifically, 
monolayer models were used to investigate sodium fluorescein uptake in correlation with cell death 
and a curved, stratified, corneal epithelial model was used to induce solution-induced corneal staining 
in vitro and correlate results with changes in cell viability and apoptosis.  An outline of the 
experimental approach is shown in Figure 4-1. 
 
Figure 4-1:  Outline of the experimental approach. BA Renu: renu-soaked balafilcon A lenses; 
BA CC: Clear Care-soaked balafilcon A lenses. 
4.2 Materials and Methods 
4.2.1 Reagents 
Keratinocyte serum-free medium (KSFM), keratinocyte growth supplements (KGS), and 
penicillin/streptomycin (Pen/Strep) solution were purchased from ScienCell (Carlsbad, California, 
USA).  Phosphate buffered saline (PBS) and Keratinocyte growth media (KGM-2) containing high 
calcium and the bullet kit were purchased from Lonza (Allendale, New Jersey, USA).  Dulbecco’s 
Modified Eagle Medium (DMEM), 1:1 DMEM in Ham’s F12 nutrient medium, fetal bovine serum 
(FBS), and TrypLE Express were purchased from Life Technologies (Burlington, Ontario, Canada).  
Propidium iodide (PI) and the FLICA caspase kits were purchased from ImmunoChemistry 
Technologies, LLC (Bloomington, Minnesota, USA).  The FLICA kits use the fluorescent probes 
FAM-VAD-FMK (green) or SR-VAD-FMK (red) for caspase detection.  FLICA is a fluorochrome-
labeled inhibitor that binds to activated caspases in cells [187].  The FLICA inhibitor can penetrate 
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the cell and is noncytotoxic.  Unbound FLICA molecules can be washed away; the fluorescent signal 
is a direct measure of the amount of active caspase that was present at the time the inhibitor was 
added. 
4.2.2 Contact Lens and Ocular Solution 
A daily-wear silicone hydrogel balafilcon A (BA; Bausch and Lomb, Rochester, New York, USA) 
was tested.  Lenses were obtained in their original packaging from the manufacturer and had a 
curvature of 8.6 mm, diameter of 14 mm, and power of -3.00 dioptres.  All lenses were used before 
their expiry date.  Whole lenses were used and were not cut before placement on the cultures. 
All contact lens solutions were sterile and came directly from the manufacturer’s bottle.  Two 
contact lens solutions were tested:  namely the hydrogen peroxide-based solution Clear Care (Alcon; 
Fort Worth, Texas, USA) and the polyhexamethylene biguanide (PHMB)-based solution renu Fresh 
(Bausch & Lomb; Rochester, New York, USA).  renu Fresh (Renu) contains HydranateTM 
(hydroxyalkyl-phosphonate), boric acid, edetate disodium, poloxamine, sodium borate, sodium 
chloride and is preserved with polyaminopropyl biguanide (0.0001%) [35].  Clear Care (CC) contains 
3% hydrogen peroxide, sodium chloride 0.79%, Pluronic 17R4, and uses a phosphate buffer system. 
Contact lenses were removed from packaging under aseptic conditions and were rinsed in 3 mL of 
PBS before incubation with lens-cleaning solution.  Lenses to be soaked in Clear Care (CC) were 
transferred to AOsept Cups and were filled with Clear Care solution for disinfection.  Renu-soaked 
contact lenses were soaked in 3 mL of renu Fresh in a 12 well polystyrene cell culture plate.  Both 
renu- and CC-saturated lenses were soaked for 24 hours before application to the stratified cultures. 
As a positive control of cytotoxicity [10], a sterile ophthalmic solution of benzalkonium chloride 
(BAK) was used from the commercially-available Moisture Eyes (ME; Bausch & Lomb; Rochester, 
New York, USA).  ME has a BAK concentration of 0.01% w/v.  ME is a proprietary solution that 
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contains other compounds such as surfactants.  These surfactants have been shown to be 
biocompatible [10,188]. 
Staurosporine (STS) is an initiator of apoptosis [189].  Staurosporine isolated from Streptomyces 
sp. was obtained from Sigma Aldrich (Oakville, Ontario, Canada).   
Fluorescein sodium ophthalmic solution (NaFl) was obtained as minims from Bausch & Lomb at a 
concentration of 2% w/v.   
4.2.3 Monolayer Cell Culture 
Telomerase-immortalized human corneal epithelial cells (hTCEpi) gifted from Dr. Danielle 
Robertson [61] were cultured in keratinocyte growth medium supplemented with the proprietary 
bullet kit; this medium may be referred to as KBM.  Fresh medium was added every other day, and 
cells were grown to 90% confluency and were used before their twentieth passage.  Adherent cells 
were removed using TrypLE Express dissociation solution.  Cells were routinely inspected for any 
morphological changes. 
Monolayers were prepared by seeding 1 x 105 cells in a 24-well polystyrene cell culture plate 
(Becton Dickinson, Mountain View, California) and were allowed to reach confluency for a full day 
after seeding.   
After achievement of a monolayer of HTCEpi, cells were fed with a total of 500 µL of solution.  
BAK-treated wells contained 1, 5, or 10% Moisture Eyes (0.0001, 0.0005, or 0.001% BAK) and STS-
treated wells contained 0.1, 0.5, or 2 µM STS.  All dilutions were performed in KBM.  All control 
wells received only KBM.  Cells were incubated for 2 or 4 hours in a sterile humidified environment 
at 37°C and 5% CO2. 
Cells were then removed from the cell culture plates using TrypLE Express dissociation solution 
and were washed via centrifugation.  Aliquots were then transferred to flow cytometry tubes.  Tubes 
contained one of three mixtures: (a) 50 µL of DMEM containing 0.5 µL of propidium iodide (PI); (b) 
  39 
50 µL of 0.05% sodium fluorescein (NaFl); or (c) diluted FITC-VAD-FMK (pan-caspase inhibitor).  
PI-treated samples were immediately analyzed by flow cytometry.  NaFl-stained samples were 
washed three times before analysis via flow cytometry.  As per manufacturer’s instructions [190], 
caspase samples were incubated for one hour at 37°C prior to washing and subsequent analysis.  PI, 
NaFl, and caspase were all analyzed separately due to the broad emission spectra from NaFl and its 
signal overlap with both PI and caspase on our flow cytometer. 
Modifications were made to the flow cytometry protocols for microscopy analysis of the samples.  
Simply, cells were left attached and washes were done in a cell culture plate.  Cells were imaged 
using a Nikon Eclipse TS100 (Tokyo, Japan) fluorescent microscope and a Nikon DS camera.   
4.2.4 Multilayer Cell Culture 
HPV-immortalized human corneal epithelial cells (HCEC) gifted from Dr. May Griffith [49] were 
cultured in keratinocyte serum-free medium with keratinocyte growth supplements (bovine pituitary 
extract and recombinant epidermal growth factor) and Pen/Strep; this medium may be referred to as 
KSFM.  Fresh medium was added every other day, and cells were grown to 90% confluency and were 
used before their twentieth passage.  Adherent cells were removed using TrypLE Express dissociation 
solution.  Cells were routinely assessed for any morphological changes. 
Curved multilayers were prepared as previously described [10].  Briefly, 5 x 105 HCEC were 
seeded on deformed Millicell-HA (mixed cellulose esters, Millipore, Billerica, Massachusetts, USA) 
inserts with a 0.45 µm pore size following a coating with collagen type I (Sciencell, Carlsbad, 
California, USA).  Silicone Press-to-Seal sheets with adhesive (Life Technologies, Burlington, 
Ontario, Canada) were punched into rings and were placed prior to seeding on the curved filter.  The 
curved multilayers were fed with KSFM on each of the basal and apical sides of the curve for the first 
seven days, with medium being exchanged every other day.  After eight days, cell differentiation was 
induced by exposing the monolayer to an air-liquid interface.  Cells were fed only on the basal side 
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with 2% FBS in 1:1 DMEM/F12 and medium was exchanged daily.  The cells grew under these 
conditions for seven days prior to experimentation. 
4.2.5 In vitro Onlay Model 
Prepared stratified cultures were fed with KSFM on the basal side.  Apically, KSFM was added to 
wet the surface and CC- or renu-soaked BA lenses were placed gently on the top of the multilayer, 
concave-side down, to fit the eye-shaped curve.  An additional amount of KSFM was added on top of 
the lens to ensure moisture retention.  Moisture Eyes was diluted to have a concentration of 0.01% or 
0.005% BAK for MTT and staining experiments, respectively.  Upon placement of the lenses, the 
stratified cultures were transferred to a humidified incubator for 2, 4, or 6 hours at 37°C and 5% CO2. 
Each plate of multilayers contains six wells.  The six wells were divided into two sets of three 
containing a no solution control, a BA CC test, and a BA renu test.  Each plate had two sets of three, 
which were run at different time points.  Multiple plates were required for one replicate of the 
experiment. 
4.2.6 MTT Assay 
After incubation, lenses and medium were removed to quantify cellular viability using a modified 
MTT assay [10].  Thiazoyl blue tetrazolium bromide (0.5 mg/mL, MTT, Sigma Aldrich, Oakville, 
Ontario, Canada) was added to the apical and basal sides of the cell culture insert and was incubated 
for 3 hours at 37°C and 5% CO2.  The MTT solution was then removed and isopropanol was added to 
both the apical and basal sides of the inserts and plates were agitated for 2 hours.  The solutions on 
the apical and basal sides were mixed and an aliquot was taken.  Samples were read in a UV-Vis 
spectrophotometer for optical density at 595 nm with a reference at 650 nm.  All results are expressed 
as relative viability compared to control cells; cells incubated in KSFM and in the absence of a 
contact lens (no lens control).  Cellular metabolic activity determined from the mixed solution is 
reported in the results section. 
  41 
4.2.7 Fluorescein Staining and Biomicroscopy 
Following lens and solution incubation, lenses and medium were removed and 2 mL of fresh 
KSFM was added on the basal side of the inserts.  1 mL of 0.2% NaFl in KSFM was added to the top 
of the insert for 1 min.  The fluorescein was then aspirated and cells were washed 3 times with PBS. 
Curved multilayer inserts were mounted on a laboratory stand inside of a small polyvinylchloride 
holder with an opaque background to enhance contrast.  The curved stratified epithelium was 
visualized with a Carl Zeiss slit lamp SL-130 (Oberkochen, Germany) with an attached Sony 3CCD 
colour video camera (Minato, Japan).  To visualize the staining, a cobalt blue excitation filter was 
used with a yellow barrier filter to enhance contrast. 
4.2.8 Cell Collection and Tissue Digestion 
Digestion and flow cytometry on the curved, stratified, corneal epithelial model has been 
previously reported [10].  After lens incubation, the medium on the top of the well was used to wash 
the contact lens and the surface of the stratified culture.  This population of cells and debris was 
collected and is referred to as the supernatant population.  Upon removal of the supernatant 
population, DMEM/10% FBS was added to the supernatant cells and the samples were centrifuged.  
Supernatant cells were resuspended in DMEM/10% FBS and prepared for flow cytometry. 
Once the supernatant population and the contact lens were removed, the multilayers were digested.  
0.25% Trypsin-EDTA was added to the basal side of the insert and to the top of the insert.  Cell 
dissociation buffer was then added to the top of the insert and cells were placed on a shaker at 120 
rpm for 45 min in a 37°C and 5% CO2 environment.  After 45 minutes, FBS was added to the inserts 
and cells were briefly resuspended via pipetting.  The cells were returned to the shaker for another 45 
minutes.  Once the cells were removed, the cell-containing media from the top of the filter was 
transferred to polypropylene tubes containing DMEM/10% FBS.  Cells were then centrifuged and 
resuspended in fresh media.  This population is referred to as the adherent population. 
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4.2.9 Flow Cytometry 
After resuspension in DMEM/10% FBS, aliquots were transferred to flow cytometry tubes.  Flow 
cytometry tubes contained FITC-VAD-FMK (pan-caspase inhibitor).  As per kit instructions [190], 
caspase samples were then washed and propidium iodide (PI) was added.  Samples were immediately 
read on a FACSVantage flow cytometer (Becton Dickinson, Mountain View, California, USA) using 
CELLQuest Software.  At least 5000 events were collected per sample.  Analysis was performed with 
CELLQuest post data acquisition. 
4.2.10 Statistical Analysis 
All results are reported as means ± standard deviation.  To evaluate the significances in monolayer 
necrosis and apoptosis, multilayer viability and caspase expression, and solution-induced corneal 
staining of the multilayers, an analysis of variance (ANOVA) was performed, followed by multiple 
pairwise comparisons using the Tukey’s Honest Significant Difference test using Statistical Analysis 
Software (SAS, Cary, North Carolina, USA).  Samples were compared to cells incubated without lens 
or solution (no lens control), as well as to cells exposed to a PBS-soaked BA lens (BA PBS control).  
Significant differences between compounds tested may also be reported.  A p value of less than 0.05 
was required for statistical significance.  The number of experiments was equal to or greater than 
three and experiments were performed on different days. 
4.3 Results 
4.3.1 Monolayer Observations 
As shown in Figure 4-2, BAK induced necrosis (as measured by PI) in a monolayer of hTCEpi.  
Cell death was also dependent on BAK concentration.  STS induced necrosis and apoptosis (as 
measured by the pan-caspase inhibitor FAM-VAD-FMK) as illustrated in Figure 4-3.  With 
increasing concentrations of staurosporine, there was a marked increase in the level of cell death 
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(apoptosis and necrosis) as compared to baseline.  0.5 and 2 µM concentrations of STS induced 
significantly higher levels of caspase and PI staining at both 2 hours (p<0.03) and 4 hours (p<0.007).   
 
Figure 4-2: Effect of varying concentrations of BAK on necrosis and sodium fluorescein 
staining in monolayers of hTCEpi.  Following exposure to 0.0001%, 0.0005%, and 0.001% BAK 
for 2 hours and 4 hours, monolayers were detached from a cell culture plate and processed for 
flow cytometry.  Cells were stained with NaFl or PI and were read immediately on a flow 
cytometer. PI intercalates with DNA in membrane-compromised (necrotic) cells and fluoresces 
strongly in this capacity.  n=3, *significantly different from NaFl ratios of fluorescence 
intensity, p<0.05, BAK: benzalkonium chloride; NaFl: sodium fluorescein; PI: propidium 
iodide. 
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Figure 4-3: Effect of varying concentrations of STS on cell death and sodium fluorescein 
staining in monolayers of hTCEpi.  Following exposure to 0.1 µM, 0.5 µM, or 2.0 µM STS for 2 
hours and 4 hours, monolayers were detached from a cell culture plate and processed for flow 
cytometry.  Cells were stained with NaFl, PI or a pan-caspase inhibitor and were read 
immediately on a flow cytometer. PI intercalates with DNA in membrane-compromised 
(necrotic) cells and fluoresces strongly in this capacity.  In the presence of activated caspases 
within cells, a fluorescent signal is observed with the probe FAM-VAD-FMK: it is thus a 
marker of apoptosis.  n=3, *significantly different from NaFl ratios of fluorescence intensity, 
p<0.05, NaFl: sodium fluorescein; PI; propidium iodide; STS: staurosporine. 
 
In both BAK and STS treated samples, levels of sodium fluorescein staining intensity decreased 
with increasing cell death.  Specifically, the proportion of cells that stained positive for sodium 
fluorescein actually decreased with increasing concentrations of staurosporine as illustrated in Figure 
4-4.  
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Figure 4-4: Flow cytometry dot plots showing percentages of cells stained positive with sodium 
fluorescein.  Monolayers of hTCEpi were grown in polystyrene cell culture plates and were 
incubated with various concentrations of staurosporine (STS) for two hours.  Control cells were 
incubated in the presence of cell culture media, alone.  Cells were then detached and processed 
for flow cytometry.  Black represents the population of sodium fluorescein-positive-stained cells 
while grey is for non-fluorescein-stained cells.  With increasing concentrations of staurosporine, 
a decrease in the fluorescence intensity of sodium fluorescein staining can be observed.  These 
plots are representative of three replicates. 
To allow for staining of both fluorescein-stained cells and caspase-positive cells, SR-VAD-FMK 
was used in the microscopy experiments.  SR-VAD-FMK fluoresces in the red spectrum, whereas 
FAM-VAD-FMK fluoresces in the green spectrum.  Microscopy of cells stained with SR-VAD-FMK 
and sodium fluorescein, as illustrated in Figure 4-5, shows that normal, healthy epithelial cells all 
were capable of uptaking sodium fluorescein.  Minimal caspase activity was detectable in the control 
samples.  Alternatively, for the BAK-treated samples after a two hour incubation, cell death was 
prevalent.  As highlighted in Figure 4-5, there was minimal overlap between the fluorescein-positive 
(green) and caspase-positive (red) cells.   
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Figure 4-5: Fluorescent microscope images of (a) control and (b) BAK-treated samples after 
staining with sodium fluorescein (green) and SR-VAD-FMK, a pan-caspase inhibitor (red).  
hTCEpi cells were grown as a sub-confluent monolayer and were incubated for two hours in (a) 
cell culture medium or in (b) a solution of 0.001% BAK.  Original images taken at 40x 
magnification. 
4.3.2 Multilayer Observations 
4.3.2.1 MTT Viability 
As shown in Figure 4-6, no difference in viability was observed between BA PBS and the no lens 
control (94±5% and 98±10% for 2 and 6 hours, respectively).  Incubation with 0.01% BAK resulted 
in a drastic reduction in viability (36±6% and 22±5% for 2 and 6 hours, respectively) as compared to 
the BA PBS control (p<0.001).  These results are in accordance with our previously published study 
[10]. 
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Figure 4-6: Effect of lens and solution combinations on cellular viability of curved stratified 
epithelium.  Cells were incubated for 2 or 6 hours with a PBS-, CC-, or Renu-soaked balafilcon 
A contact lens.  0.01% BAK is used a positive cytotoxic control.  Viability was measured by the 
MTT assay and is expressed as a percentage relative to cells grown in the absence of a contact 
lens or ophthalmic solution (control).  n=4, *significantly different from BA PBS control, p < 
0.05.  BA: balafilcon A, BAK: benzalkonium chloride, CC: Clear Care, PBS: phosphate 
buffered saline. 
The slightly reduced viability observed with BA CC was not statistically significantly different 
compared to the BA PBS control.  While BA Renu had a lower viability compared to BA PBS, 78±9 
at 2 hours (p<0.04) and 81±13 at 6 hours (p<0.01), the reduction in viability with BA Renu did not 
reach statistical significance when compared to BA CC.   
4.3.2.2 Caspase Expression 
BAK proved to be a strong positive control, with increases in caspase expression relative to 
control (Figure 4-7).  No significant upregulation of caspases was observed with BA lenses soaked in 
PBS.  Neither BA lenses soaked in Clear Care nor in Renu induced a statistically significant increase 
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in caspase expression when compared to a BA lens soaked in PBS.  However, it should be noted that 
the supernatant portion of cells shows a mild upregulation with BA Renu (1.27 ± 0.5 and 1.28 ± 0.2, 2 
and 6 hours, respectively) versus BA CC (1.04 ± 0.2 and 0.98 ± 0.1, 2 and 6 hours, respectively).  The 
adherent population showed no upregulation of apoptosis in any of the lens and solution 
combinations. 
 
Figure 4-7: Effect of contact lens and solution interactions on caspase expression in the 
supernatant and adherent populations.  Following exposure to stimuli after 2 or 6 hours, the 
curved, stratified cultures of human corneal epithelial cells were digested with trypsin and 
EDTA.  Caspase expression was measured by flow cytometry and is expressed as a ratio relative 
to its expression on cells incubated in the absence of a contact lens or solution (control).  n=3, 
*significantly different from the BA PBS control, p<0.05.  BA:  balafilcon A; BAK: 
benzalkonium chloride; CC: Clear Care; PBS: Phosphate buffered saline. 
Caspase samples were also counterstained with propidium iodide to investigate changes in the 
necrotic population of cells, however, all values for lens and solution combinations remained similar 
to no lens controls (data not shown). 
4.3.2.3 Corneal Staining 
Following incubation with lens and solution combinations, the curved, stratified cultures were 
subjected to fluorescein staining and slit lamp biomicroscopy in a manner similar to clinical 
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examination.  The curved, stratified epithelium was capable of presenting a micropunctate staining 
pattern and this is the first time, to our knowledge, that this has been replicated in vitro.  Prior, slit 
lamp biomicroscopy has only been performed on monolayers [179].   
There was variability in the amount of staining observed with the curved multilayer model (CML) 
as control wells that were treated solely with cell culture media occasionally expressed micropunctate 
staining.  To better understand this phenomenon of variability in staining of our curved, stratified 
multilayers, we investigated how staining happens over time.  As shown in Figure 4-8, formazan 
staining indicated a seemingly linear increase in surface coverage by the HCEC.  However, sodium 
fluorescein staining of the curved model showed a drastically different pattern during growth of the 
multilayers (Figure 4-9).   
 
Figure 4-8: Growth of a curved stratified epithelium.  Human corneal epithelial cells were 
grown for 15 days and were stained with MTT on days 1, 4, 7, 11, and 15 of growth.  Formazan 
(purple) staining indicates viable cells.   
Following one day after seeding, all cells uptake sodium fluorescein, which is consistent with our 
own monolayer observations, and with the literature, reproducibly showing that sub-confluent 
monolayers uptake sodium fluorescein [157,158,179].  However, as the monolayer becomes more 
confluent, this staining decreases in both intensity and distribution until Day 7 where there is no 
observable staining.  It is worth noting the possibility that these cells still uptake sodium fluorescein, 
but lack the necessary contrast to observe staining.  Cells are differentiated on Day 8, and on Day 9 
(one day after differentiation), there is still no observable staining.  On Day 11, intensity and 
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concentration of staining is the greatest that has been observed with our model.  It is also important to 
note that staining on Day 11 could be observed by different cells on different focal points, implying 
that superficial layers of cells are not alone responsible for fluorescein staining at this time point. 
 
Figure 4-9: Slit lamp evaluation of a curved stratified epithelium during growth.  Human 
corneal epithelial cells were grown for 15 days.  Cells were stained with sodium fluorescein at 
days 1, 4, 5, 7, 9, 11, 13, and 15 and were imaged using a slit-lamp biomicroscope with a cobalt 
blue excitation filter and a yellow barrier filter to enhance contrast.  An air-liquid interface was 
established on day 8.  All images were taken at 32x magnification.  This is representative of 
three different observations. 
To determine if the CML was sensitive to solution-induced corneal staining, we first developed a 
staining score system as shown in Figure 4-10.  A score of zero was given if there was no observable 
staining across the multilayer, a one was given if there was a minimal amount of corneal staining, a 
two was given if there was a decent amount of corneal staining, and a three was given if staining was 
prevalent across the multilayer.  On occasion, some scores were hard to judge as staining may have 
been intensely localized to a portion of the multilayer, rather than been evenly distributed across the 
multilayer.  
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Figure 4-10: Examples of different staining scores of sodium-fluorescein stained curved 
stratified epithelium.  Cells were incubated with lens and solution combinations and were then 
stained with sodium fluorescein and imaged using a slit-lamp biomicroscope with a cobalt blue 
excitation filter and a yellow barrier filter to enhance contrast.  Original images on the left; 
contrast enhanced images on the right.  All images taken at 8x.   
Figure 4-11 shows the response of the CML to solution-induced corneal staining.  Our model 
appears to be most sensitive at the 2 hour time point, where an almost statistically significant 
differences can be observed between BA Renu and BA CC (p<0.08) and between BA Renu and a no-
lens control (p<0.07).  By 4 hours and 6 hours, there are relatively no differences in the levels of 
staining between control, BA Renu, and BA CC.   
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Figure 4-11: Relative levels of sodium fluorescein staining of the curved stratified epithelium.  
Cells were incubated for 2, 4, or 6 hours with different lens and solution combinations.  
Following lens incubation, lenses were removed and epithelium were stained with sodium 
fluorescein.  Resulting staining patterns were given a score of 0-3 as described in Figure 4-10.  
n=5, * statistically different from no lens, no solution control (p<0.07), # statistically different 
from BA CC (p<0.08).  BA: balafilcon A, CC: Clear Care. 
4.4 Discussion 
Our monolayer studies are in agreement with the work performed by Bakkar et al. [158] and by 
Bandamwar et al. [179].  These two studies have performed monolayer experiments to confirm two 
major observations:  that fluorescein is localized intracellularly and that dead cells do not uptake 
sodium fluorescein.  Intracellular staining was first proposed by Feenstra and Tseng in 1992 [157] 
and was more recently demonstrated by Glasgow’s group [163,177].  Our research group has also 
observed intracellular staining by sodium fluorescein and we have previously confirmed that ex vivo 
collected corneal epithelial cells stained with fluorescein do not stain with propidium iodide [7,178]   
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The recent work of Bakkar has shown that active transport is responsible for uptake into L929 
murine fibroblasts as there is a temperature-dependence upon both uptake and release of fluorescein 
by cells [158].  Bandamwar et al. performed a similar study, but arrived at a result that apoptotic cells 
are responsible for hyperfluorescent cells [179].  Our research group, in collaboration with the Centre 
for Contact Lens Research at the University of Waterloo, has also demonstrated that 
hyperfluorescence can be observed occassionally with apoptotic cells [178].  The present study does 
not strictly correlate with these results and may be a result of differences in experimental methods.  
Namely, samples in this work were analyzed via flow cytometry and were removed via trypsinization.  
Bandamwar et al. used a different cell line, different method of apoptosis induction, and a different 
marker of apoptosis [179].  It has been previously shown that FLICA markers of caspase activation 
(specifically FAM-VAD-FMK) may provide more information on early apoptosis whereas Annexin 
V may be more related to late apoptosis [191].  However, the difference in results likely comes from 
the difference of hyperfluorescence versus general fluorescein staining.   
Monolayer in vitro models have much utility, but are limited in many ways because of their 
simplicity and hypersensitivity.  Our current study also lacked a positive control that could effectively 
induce corneal staining or increase the levels of fluorescein staining.  This is all the more complicated 
by the fact that cells in a monolayer already stain positive for NaFl (as illustrated in Figure 4-4).  To 
date, no positive control for SICS has been found reliably in vitro, as BAK does not appear to induce 
a similar response.   
In the development of an in vitro stratified model of sodium fluorescein staining, it was important 
to evaluate how fluorescein staining changes as a result of multilayer stratification.  It has been shown 
in sub-confluent monolayers that uptake of sodium fluorescein is consistent and present among all 
cells, even across cell types [157,158,179].  In the stratified cultures used in our experiments, one day 
after seeding-while the cells are still in a monolayer-all cells displayed a similar, unilateral uptake of 
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sodium fluorescein.  As the HCEC continue to form a confluent monolayer, the overall presence and 
intensity of fluorescein staining decreased even though more cells were present on the surface of the 
curve as demonstrated by formazan staining.  By the time cultures were confluent, the level of 
staining was almost negligible.  Thus, it is likely that there is some sort of reorganization of the 
multilayer that occurs during stratification which allows for the multilayer to become susceptible to 
stain with fluorescein.  As medium was changed and an air-liquid interface was provided to promote 
stratification, no immediate changes were observed (Day 9), but by Day 11, there was a significant 
and intense level of fluorescein staining.  It should also be noted that this staining occurred 
throughout different focal points, implying that more than the superficial layer stained with sodium 
fluorescein.  As the multilayer completed its stratification (Day 15), this total level of staining was 
reduced to being unobservable.  These progressive changes in sodium fluorescein staining suggest 
that as the cells stratify, they undergo a reorganization that allows for a susceptibility to sodium 
fluorescein uptake.  Or, possibly, this reorganization allows for enhanced contrast of the human 
corneal epithelium.   
Two contact lens and multipurpose solution combinations were tested in this study, namely BA 
Renu and BA CC.  These solutions were compared to previously published controls of BA PBS and 
BAK which both performed as expected [10].  BA Renu is recognized to induce corneal staining in 
vivo [36] and has been used as a positive control of SICS in many studies [178,192,193].  Conversely, 
BA CC is known to be a suitable control as evidence shows that it stains much less frequently than 
other lens and solution combinations [36,38,165,192,194].  To our knowledge, this is the first time 
that staining has ever been induced by these lens-solution combinations in vitro. 
Corneal staining has been shown to peak in vivo at around 1 hour after lens insertion and plateau 
until 2 hours before decreasing in intensity [192,195,196].  The CML shows a somewhat similar 
response with the highest level of staining for BA Renu at 2 hours, and generally lower at 4 and 6 
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hours.  However, this result did not achieve statistical significance (p=0.21).  BA CC showed almost 
no time dependence (p=0.95) which suggests that staining for BA CC may have been heavily 
influenced by model variability.  While our control wells, incubated with cell culture media alone, 
also showed variable levels of staining, any cultures incubated with 0.005% BAK did not show any 
staining whatsoever, further confirming that BAK cannot be used as a control for SICS. 
Flow cytometry of the multilayers confirm that BAK samples induce both apoptosis and necrosis 
in the cell population.  Given the lack of a dynamic system and a tear dilution, such as blinking and 
tear exchange in vivo, the response of the stratified curved epithelium may likely be overestimated in 
this in vitro model, however, it serves as a good control to assess cell death.  Across all lens and 
solution combinations, only BA Renu showed minimal upregulation of caspases at 2 hours.  In both 
the monolayer and multilayer models, fluorescein staining did not correlate with a significant increase 
in cell death.  In a stratified in vitro model, or even SICS in vivo, only a small percentage of the 
superficial layers of the epithelium stain with a micropunctate fluorescein pattern.  It may therefore be 
possible that these cells are damaged, but in the context of digesting a tissue via flow cytometry, they 
would not be significant in an entire population of epithelial cells.  Nevertheless, it may be possible 
that a slight upregulation of caspases or slight decrease in viability could provide enough of a 
destabilization of epithelial integrity to increase microbial susceptibility.  It may be possible that 
incubation in a dynamic environment such as the tear replenishment system, which replicates the 
fluidic component of blinking in vitro [11], could affect solution release from lenses and their 
subsequent interaction with the corneal epithelium.  This could help identify differences between lens 
and solution combinations, and requires further research. 
While cell death has been one mechanism that has been implicated in sodium fluorescein staining, 
mucin disruption has been another.  It has been previously reported by Gordon et al. that such a 
disruption in the mucin glycocalyx could allow for fluorescein staining to occur and thus put the 
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cornea at risk of infection [83].   In a monolayer study using human corneal limbal epithelial cells, the 
authors noted that rose bengal staining as a result of multipurpose solution exposure may lead to a 
loss of MUC16 and consequently have increased infection [83].  It has also been reported that 
exposure to MPS containing boric acid downregulate mucin expression in vitro and in vivo [197-199].  
Rose bengal staining has been correlated with solution-induced corneal staining [193], and 
fluorescein staining has also been postulated to occur as a result of mucin loss [177].  In a recent 
study by Gorbet et al., BA Renu was shown to have higher rates of shedding of corneal epithelial 
cells from the ocular surface as compared to BA CC [178].  With a limited sample size (8 
participants), staining was also shown to be highest at 2 hours, and shedding was highest at 4 hours of 
lens wear – both were reduced at 6 hours.  It has yet to be confirmed whether this change in shedding 
correlates with changes in mucin expression in the ocular surface epithelium.   
Increased infection with staining has also been observed in vivo.  7% of fluorescein staining with 
lens wear coincides with both symptomatic and asymptomatic corneal infiltrative events [165], but 
SICS may not be causative of these events [200].  It was also recently reported there is no significant 
difference in comfort between BA Renu vs BA CC [201].  Susceptibility to infection could be a result 
of reduced barrier function, as it has been shown in a pilot clinical study that barrier function is 
reduced with lens and solution combinations that induce corneal staining [202]. 
Overall, fluorescein staining may not be a very sensitive metric of ocular health and of lens and 
solution biocompatibility.  Uptake and release of sodium fluorescein by monocarboxylate transporters 
may be easily affected by pH [182], which could be affected either by multipurpose solution 
components [161] or by changes in physiological conditions in disease such as dry eye [203].  
Intensity, prevalence, or resolution of corneal staining may be affected by humidity [160,204], 
punctum plugging [205,206], artificial tear substitutes [207-209], and smoking [210].  All of which 
could potentially affect the ocular surface mucin glycocalyx. 
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Over the last century, vital staining with sodium fluorescein and its derivatives, namely rose 
Bengal and lissamine green, has been able to provide us with a lot of information about changes to the 
health of the ocular surface.  However, the aetiologies with which cells stain at a metabolic level may 
often be insufficient for diagnostic purposes.  Apoptotic cells may have a hyperfluorescence, and yet 
dead cells do not fluoresce at all.  Mucin disruption may be responsible for cells to uptake fluorescein, 
and yet a normal, healthy cornea, may exhibit cells that hyperfluoresce with fluorescein.  It has been 
suggested that the fluorescein-labelled octadecyl ester (FODE) may be a better diagnostic stain given 
its specificity for tear lipocalin in mucin-depleted areas of the ocular surface [203].  Overall, there is a 
definite requirement by academia and industry for novel dyes with improved ability to diagnose 
dysregulation of health at the ocular surface. 
4.5 Conclusions 
Investigation of hyperfluorescent corneal epithelial cells may be a biomarker of susceptibility, 
however, monolayer and multilayer corneal epithelial cultures that indicate chronic damage and are 
prevalent with apoptotic and necrotic cell populations do not uptake sodium fluorescein.   
The curved, stratified, corneal epithelium enabled the first reproduction of micropunctate corneal 
staining in vitro.  BA Renu and BA CC are both biocompatible, though there are acute differences 
between the response of cultures to these different lens and solution combinations.  While BA Renu 
shows signs of solution-induced corneal staining in our in vitro model, this was only associated with a 
slight downregulation in viability and a slight increase in apoptosis.  This may indicate a loss of some 
of the barrier mechanism of the corneal epithelium, but further detailed investigation is required. 
Fluorescein staining is responsible for the clinical finding of lens and solution interaction.  
However, given the ability of fluorescein staining to stain in healthy epithelium, and its uptake and 
release to be affected by different environmental and physiological parameters, there is a need for 
new dyes with greater specificity as probes of ocular surface health and disease. 
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As the development of novel ocular stains and the improvement of lens and solution interaction 
continues, our curved, stratified epithelial model has been shown to be sensitive under a wide array of 
parameters and may be a suitable in vitro model for the exploration of novel lenses, solutions, and 
stains. 
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Chapter 5   
Inability to replicate tear-film neutrophil phenotype 
using blood-isolated neutrophils, in vitro 
 
A story of  blood, sweat, and tears.  
 
 
 
5.1 Introduction 
When the eye is closed for a prolonged period of time, there is an influx of neutrophils on to the 
ocular surface [92,123,125].  Following discussion with several investigators, these neutrophils have 
since been termed by our research group “tear-film neutrophils” [16].  These neutrophils have been 
shown to be alive, but are limited in their ability to respond to inflammatory stimuli.  A study where 
we compared and contrasted the response of tear-film neutrophils and neutrophils isolated from whole 
blood, or “blood-isolated neutrophils” was recently completed [16].  The main results of the previous 
study are depicted by Figure 5-1, where it can easily be observed that receptor upregulation on tear-
film neutrophils is negligible in comparison to blood-isolated neutrophils.  The goal of the present 
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investigation was to determine if closed-eye environmental conditions could be used to induce a 
phenotypic change in blood-isolated neutrophils in vitro. 
 
Figure 5-1: Comparison of baseline membrane receptor expression of tear-film neutrophils 
versus blood-isolated neutrophils.  Symbols represent relative ratios as compared to 
unstimulated (rest) controls.  All data reprinted from [16]. 
Our research group has focused on the development of in vitro models of biocompatibility at the 
ocular surface and specifically, we have created a 3D curved, stratified model of the human corneal 
epithelium [10], and also fabricated a tear replenishment system that mimics the fluidic effect of 
blinking on these 3D cultures [11].  While our curved multilayer (CML) model is capable of 
providing strong estimates of cytotoxicity, the model does not incorporate any inflammatory 
mechanisms that would occur in vivo.  Ultimately, it is hoped that future models will include 
inflammatory cells, to provide better indications of biocompatibility (or lack thereof), but firstly, there 
needs to be an improved understanding of the role of tear-film neutrophils in ocular surface 
inflammation. 
Neutrophils, or polymorphoneuclear leukocytes (PMNs), were thought to be terminally 
differentiated cells that are incapable of altering their gene expression following differentiation and 
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maturation in the bone marrow [211].  This has been proven to be untrue as subsets within the 
neutrophil population have the ability to actively change their gene expression to respond to 
inflammation [212,213], and can even reverse transmigrate across the endothelium [214].  
Heterogeneity in the neutrophil population is not a new concept as oral [215-217], airway [218], and 
nasal [219] neutrophils have all shown a refractory behavior.   
Our previous study concluded that artificial tear solution had a small, but significant, effect on the 
activity of blood-isolated neutrophils [16].  The tear film contains many proteins that participate in 
the ocular surface inflammatory response [93].  Notably, lactoferrin is a potent anti-inflammatory 
protein [220], and it may be possible that extended incubation with anti-inflammatory proteins could 
affect the behavior of blood-isolated neutrophils. 
The corneal epithelium has developed many mechanisms to withstand different types of 
compromise and infection through the use of receptor expression – such as toll-like receptors, mucin 
receptors – or release of soluble factors such as cytokines [221] or lipid autocoids [106].  It has been 
observed that lymphocytes adhere and show a differential expression when incubated with cultured 
human corneal epithelial cells (HCEC) [222], and it is possible that, for the preservation of vision, 
neutrophils adopt a quiescent phenotype with HCEC.   
One of the main ways that the closed eye differs from the open eye is the level of oxygenation at 
the ocular surface.  Oxygen is important for the maintenance of corneal integrity and homeostasis 
[223].  In open eye conditions, the cornea receives most of its oxygen from the atmosphere which has 
a partial pressure of 20.9% O2 (sea level) [224], and the epithelium receives the oxygen through its 
diffusion in the tear film [225].  However, under closed eye conditions, the level of oxygenation at the 
ocular surface decreases significantly.  Three different studies have reported values around 8%, with 
the first being Fatt and Bieber who observed a value of 7.4% O2 in one subject, followed by Efron 
and Carney who reported an average of 7.7% O2 in 12 subjects [226], and finally Holden and 
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Sweeney who found an average of 8.2% O2 in 16 subjects [227].  The cornea still receives oxygen in 
closed eye conditions, both from the palpebral conjunctival blood vessels [94], and from eyelid 
flicker during sleep [225,228].  Oxygen deprivation has been shown to specifically affect neutrophils 
both in vitro and in vivo [229-231], with effects on neutrophil survival, expression of neutrophil 
membrane receptors, and release of cytokines and reactive oxygen species. 
Three closed eye conditions were tested alone and in combination on blood-isolated neutrophils to 
determine if environmental conditions could alter expression of neutrophil membrane receptors and 
induce a tear-film neutrophil phenotype.  Blood-isolated neutrophils were incubated for six hours 
with artificial tear solution, in a co-culture with human corneal epithelial cells, and under hypoxic 
(2% O2) conditions.  Changes in cell culture receptor expression were monitored using flow 
cytometry. 
5.2 Materials and Methods 
5.2.1 Reagents and Antibodies 
LPS (Escherichia coli serotype 0111:B4), phorbol-12-myristate-13-acetate (PMA), N-Formyl-L-
methionyl-L-leucyl-L-phenylalanine (fMLP), endotoxin-free water, ethylenediaminetetraacetic acid 
(EDTA), and paraformaldehyde was purchased from Sigma-Aldrich Co. (Oakville, Ontario, Canada).   
Keratinocyte serum-free medium (KSFM), keratinocyte growth supplements (KGS), and 
penicillin/streptomycin (Pen/Strep) solution were purchased from ScienCell (Carlsbad, California, 
USA).  Phosphate buffered saline (PBS) was acquired through Lonza (Allendale, New Jersey, USA).  
Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), and TrypLE Express were 
purchased from Life Technologies (Burlington, Ontario, Canada).  All other chemicals were of 
analytical reagent grade. 
Fluorescein isothiocyanate (FITC) conjugated monoclonal antibodies against human CD11b and 
CD66b, R-phycoerythrin (PE) conjugated monoclonal antibodies against human C3aR and CD54, 
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and R-phycoerythrin-cytochrome 5 (PE-Cy5) conjugated monoclonal antibody against CD45 were 
purchased from Becton Dickinson Pharmingen (San Diego, California, USA). 
The FLICA caspase kit was purchased from ImmunoChemistry Technologies, LLC (Bloomington, 
Minnesota, USA).  The FLICA kit uses the fluorescent probe FAM-VAD-FMK for caspase detection.  
FLICA is a fluorochrome-labeled inhibitor that binds to activated caspases in the cells [187].  The 
FLICA inhibitor can penetrate the cell and is noncytotoxic.  Unbound FLICA molecules can be 
washed away; the fluorescent signal is a direct measure of the amount of active caspase that was 
present at the time the inhibitor was added. 
5.2.2 Peripheral Blood Neutrophil Isolation 
This study was conducted in accordance with the tenets of the Declaration of Helsinki and 
received ethics clearance from the University of Waterloo ethics committee.  5 participants (2 male 
and 3 female) donated their blood for the purpose of these experiments. 
Blood was drawn from healthy participants who were free of medication for at least 48 hours.  
Low molecular weight heparin (10 U/mL) was used as an anticoagulant.  Platelet-rich plasma was 
first removed by centrifugation at 100g.  Blood leukocytes were then isolated using density gradient 
centrifugation (Polymorphprep, Axis Shield PoC AS, Oslo, Norway) followed by three washes in 
serum-containing media and EDTA, and were ultimately resuspended in DMEM/10% FBS or an 
Artificial Tear Solution (ATS).  The artificial tear solution was a solution of phosphate-buffered 
saline containing tear film proteins as detailed in Table 5-1. 
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Table 5-1: Components of the artificial tear solution.  Adapted from [232]. 
Salt Component Protein Component  
Sodium Chloride  3.0 mM  Bovine Albumin 32.0 mg/mL  
Potassium Chloride  24.0 mM Hen egg lysozyme  3.6 mg/mL 
Sodium Citrate Monobasic  26.0 mM Bovine submaxillary mucin 3.6 mg/mL  
Glucose   Bovine colostrums lactoferrin 24.0 mg/mL  
Urea   Bovine immunoglobulin G  48.0 mg/mL  
Calcium Chloride   0.5 mM    
Sodium carbonate 12.0 mM   
Potassium hydrogen carbonate 3.0 mM    
Sodium phosphate dibasic 24.0 mM   
Hydrochloric acid (10M) 26.0 mM   
MilliQ Water    
    
 
5.2.3 6 Hour Incubation 
To try and induce a tear-film phenotype in blood-isolated neutrophils, varying six-hour 
incubations were performed as shown in Figure 5-2.  Incubation was performed in either ATS or 
DMEM/10% FBS, under either hypoxic or normoxic conditions, in either a polypropylene tube or in 
a cell culture plate on top of a monolayer of human corneal epithelial cells.  Each batch of 
experiments was performed at the same time on the same day to test all conditions using the same 
blood-isolated neutrophils.  Preliminary experiments were also performed with a polystyrene cell 
culture plate in absence of human corneal epithelial cells, but there was significant attachment and 
activation of the blood-isolated neutrophils, so further experimentation was discontinued. 
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Figure 5-2: Protocol overview.  Blood-isolated neutrophils were incubated for six hours in every 
combination of DMEM/10%FBS (FBS) or artificial tear solution (ATS), in a polypropylene 
tube or with a monolayer of human corneal epithelial cells, or in a normoxic or hypoxic 
condition. 
Hypoxia 
Hypoxia was induced through incubation of tubes and plates in a Billups-Rothenburg modular 
incubation chamber (Del Mar, California, USA).  The sealed, air-tight chamber was flushed for 5 
minutes with a gas mixture containing 5% CO2, 2% O2, and a balance of nitrogen.  The chamber was 
then incubated at 37°C for 6 hours.  Normoxic conditions were established through simple incubation 
in a humidified cell culture incubator at 37°C and 5% CO2.  
Cell Culture 
HPV-immortalized human corneal epithelial cells (HCEC) gifted from Dr. May Griffith [49] were 
cultured in keratinocyte serum-free medium with keratinocyte growth supplements (bovine pituitary 
extract and recombinant epidermal growth factor) and Pen/Strep; this medium may be referred to as 
KSFM.  Fresh medium was added every other day, and cells were grown to 90% confluency and were 
used before their twentieth passage.  Adherent cells were removed using TrypLE Express dissociation 
solution.  Cells were routinely observed for any morphological changes. 
Monolayers were prepared by seeding 1 x 105 cells in a 24-well polystyrene cell culture plate 
(Becton Dickinson, Mountain View, California, USA) and were allowed to reach confluency for a full 
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day after seeding. After achievement of a monolayer of HCEC, cells were fed with a total of 500 µL 
of DMEM/10%FBS or ATS immediately before the neutrophils were added. 
5.2.4 Caspase Activity 
After incubation, aliquots were transferred to flow cytometry tubes. Half of the tubes contained a 
dilute solution of staurosporine (5 x 10-10 mol/test) which is known to induce apoptosis [189].  As a 
positive control, staurosporine was used to “stimulate” the cells to ensure that the neutrophils were 
still capable of becoming apoptotic, and hence implying that they were not dead.  Staurosporine-
treated samples were incubated at 37°C for 30 minutes to induce cell death.  Flow cytometry tubes 
contained FITC-VAD-FMK (pan-caspase inhibitor).  As per kit instructions [190], caspase samples 
were incubated for one hour followed by three washes.  Samples were immediately read on a flow 
cytometer. 
5.2.5 Cell Stimulation 
Following the 6 hour incubation of the blood-isolated neutrophils, the cells were then incubated 
with an inflammatory stimulus.  Two stimuli, that are recognized to induce an inflammatory response 
in leukocytes, were used: lipopolysaccharide (10,000 EU/mL final concentration), also known as 
endotoxin [128]; and fMLP (16.7 nM final concentration), which induces a G-protein coupled 
receptor mediated physiological activation [233].  Samples were divided in aliquots (Rest, i.e. 
unstimulated; LPS-stimulated; fMLP-stimulated).  Stimulation was performed at 37°C for 15 minutes 
(fMLP) and 30 minutes (LPS). 
5.2.6 Expression of Membrane Receptors on Leukocytes 
After incubation with stimulus, 30 µL of cell suspension was transferred into tubes containing 
fluorescently-labelled antibodies against CD11b, CD45, CD54, CD66b, or C3aR and were incubated 
for 30 minutes at room temperature in the dark.  At the end of the incubation, samples were diluted 
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and fixed with paraformaldehyde (1% final concentration).  All samples were analyzed on the flow 
cytometer within 5 days. 
5.2.7 Flow Cytometry 
All samples were acquired on a Becton Dickinson FACSVantage flow cytometer (Mountain View, 
California) using CELLQuest Software.  At least 5000 neutrophil events were acquired.  Appropriate 
isotype controls were used with each experiment.  Data analysis was performed using CELLQuest 
post data acquisition. 
The following nomenclature is being used when reporting all results:  neutrophils collected after 
sleep are referred to as “tear-film neutrophils”, neutrophils isolated from whole blood as “blood-
isolated neutrophils”.  To allow for comparisons between the different types of neutrophils, the mean 
fluorescence intensity in arbitrary units (AFU) as well as the ratio of the fluorescent intensities of rest 
(unstimulated) versus stimulated are presented. 
5.2.8 Statistical Analysis 
All subsequent data collected with blood-isolated neutrophils was collected from the same donors, 
within the same time period, and using the same settings, to allow for statistical comparison with the 
tear-film neutrophils of [16]. 
All results are reported as means ± standard deviation.  To evaluate the significance of the 
differences in the ratio of cell activation, an analysis of variance (ANOVA) was performed followed 
by multiple pairwise comparisons using the Tukey test.  Analysis was performed using Statistical 
Analysis Software (SAS; Cary, North Carolina, USA) and a p value of less than 0.05 was required for 
statistical significance.  For all experiments, the number of participants was equal to or greater than 3. 
5.3 Results 
Neutrophils were isolated from whole blood and were incubated in varied conditions to mimic 
some of the hallmarks of the closed eye environment:  regular cell culture medium versus an artificial 
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tear solution; with or without a monolayer of human corneal epithelial cells; and in a normoxic (21% 
O2) or hypoxic (2% O2) environment.   
After six hours of incubation in DMEM/10% FBS at 37°C and 5% CO2, under normoxic 
conditions and in a polypropylene tube, blood-neutrophils remained capable of responding to 
inflammatory stimuli as shown in Figure 5-3.  Following exposure to HCEC, blood-isolated 
neutrophils showed an increased expression of CD11b (cell-cell interaction) and CD66b 
(degranulation) in response to stimulation with LPS and fMLP.  ATS changed the ability of blood-
isolated neutrophils to activate as shown by a decrease in the response of CD11b and CD66b 
following stimulation with LPS.  However, incubation in ATS showed an increase in the expression 
of CD11b and CD66b following stimulation with fMLP.  Finally, incubation in hypoxic conditions 
showed negligible difference from incubation in normoxic conditions. 
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Figure 5-3: Comparison of tear-film neutrophil expression versus blood-isolated neutrophil 
expression following a 6 hour incubation under varied conditions.  Neutrophils were isolated 
from whole blood using density gradient centrifugation and were incubated for six hours in 
different incubation media (DMEM/10%FBS vs ATS), with and without a monolayer of human 
corneal epithelial cells, and in a normoxic (21% O2) or hypoxic (2% O2) environment.  
Following incubation, cells were collected and were stimulated with fMLP or LPS.  Neutrophils 
were assessed for membrane receptor expression of CD11b and CD66b using flow cytometry.  
All data is reported as ratios versus an unstimulated (rest) sample.  The dotted line indicates the 
rest value normalized to 1.  Tear-film neutrophil data is at baseline and is reprinted from [16].  
n=3-5, *significantly different from rest values, p<0.05, FBS: fetal bovine serum; ATS: artificial 
tear solution; HCEC: human corneal epithelial cells; LPS: lipopolysaccharide; fMLP: n-
formyl-methionyl-leuycl-phenylalanine. 
Under closed-eye conditions for six hours, i.e. in an artificial tear solution, with exposure to 
human corneal epithelial cells, and in a hypoxic environment, the phenotype of blood-isolated 
neutrophils was unable to mimic the expression of tear-film neutrophils in vitro as shown in Figure 
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5-4.  fMLP stimulus induced a dramatic increase in CD11b and CD66b receptor expression (p<0.002) 
and LPS induced a higher, though statistically insignificant expression than tear-film neutrophils. 
 
Figure 5-4: Comparison of tear-film neutrophil expression versus blood-isolated neutrophil 
expression following a 6 hour incubation in closed-eye conditions.  Neutrophils were isolated 
from whole blood using density gradient centrifugation and were incubated for six hours in 
ATS, with a monolayer of human corneal epithelial cells, and in a hypoxic environment (2% O2) 
to simulate closed-eye conditions in vitro.  Following incubation, cells were collected and were 
stimulated with fMLP or LPS.  Neutrophils were measured for membrane receptor expression 
of CD11b and CD66b using flow cytometry.  All data is reported as ratios versus an 
unstimulated (rest) sample.  The dotted line indicates the rest value normalized to 1.  Tear-film 
neutrophil data is at baseline and is reprinted from [16].  n=3, *significantly different from rest 
values, p<0.05, FBS: fetal bovine serum; ATS: artificial tear solution; HCEC: human corneal 
epithelial cells; LPS: lipopolysaccharide; fMLP: n-formyl-methionyl-leuycl-phenylalanine. 
Blood-isolated neutrophils were tested for apoptosis (Figure 5-5) using the marker FAM-VAD-
FMK which binds to activated caspases within cells and results in a strong fluorescence.  Caspase 
levels remained low following a six hour incubation, and only a minimal increase in fluorescence 
intensity was observed when cells were incubated with HCEC, 19 ± 3AFU versus 12 ± 3 without 
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HCEC (p<0.08).  All neutrophils were able to undergo apoptosis following incubation with 
staurosporine, indicating that, despite the 6 hour incubation under various conditions, the blood-
isolated neutrophils remain alive and functional given the induction of the intracellular mechanisms 
of apoptosis. 
 
Figure 5-5: Relative levels of caspase expression of blood-isolated neutrophils following 6 hour 
incubation under various conditions.  Neutrophils were isolated from whole blood using density 
gradient centrifugation and were incubated for six hours in different incubation media 
(DMEM/10%FBS vs ATS), with and without a monolayer of human corneal epithelial cells, and 
in a normoxic (21% O2) or hypoxic (2% O2) environment.  Following incubation, cells were 
collected and processed for flow cytometry.  Cells were stained with a pan-caspase inhibitor 
FAM-VAD-FMK which fluorescently binds to caspases within cells and is a marker of 
apoptosis.  n=3, FBS: fetal bovine serum; ATS: artificial tear solution; HCEC: human corneal 
epithelial cells. 
Across the rest of the markers tested, CD54 and C3aR showed upregulation amongst the blood 
samples as shown in Figure 5-6.  CD45 remained mostly unchanged, as expected, given that it is a 
pan-leukocyte marker and less of a marker of neutrophil activation.   
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Figure 5-6: Comparison of tear-film neutrophil expression versus blood-isolated neutrophil 
expression following a 6 hour incubation under varied conditions (ratio).  Neutrophils were 
isolated from whole blood using density gradient centrifugation and were incubated for six 
hours in different incubation media (DMEM/10%FBS vs ATS), with and without a monolayer 
of human corneal epithelial cells, and in a normoxic (21% O2) or hypoxic (2% O2) environment.  
Following incubation, cells were collected and were stimulated with fMLP or LPS.  Neutrophils 
were measured for membrane receptor expression of CD11b, CD45, CD54, CD66b and C3aR 
using flow cytometry.  All data is reported as ratios versus an unstimulated (rest) sample.  
Standard deviation is not included to improve readability, but is roughly 25% of the reported 
value.  Tear-film neutrophil data is at baseline and is reprinted from [16].  n=3-5, *significantly 
different from rest values, p<0.05, FBS: fetal bovine serum; ATS: artificial tear solution; 
HCEC: human corneal epithelial cells; LPS: lipopolysaccharide; fMLP: n-formyl-methionyl-
leuycl-phenylalanine. 
While the ratio provides a good method to see the ability of neutrophils to upregulate surface 
receptors, it does not allow for a comparison between unstimulated controls.  In Figure 5-7, the raw 
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fluorescent data shows that the overall level of expression in tear-film neutrophils is significantly 
higher as compared to the resting level of blood-isolated neutrophils after a six hour incubation, and is 
even higher than the activated level in terms of CD54 and CD66b. 
 
 
Figure 5-7: Comparison of tear-film neutrophil expression versus blood-isolated neutrophil 
expression following a 6 hour incubation under varied conditions (raw).  Neutrophils were 
isolated from whole blood using density gradient centrifugation and were incubated for six 
hours in different incubation media (DMEM/10%FBS vs ATS), with and without a monolayer 
of human corneal epithelial cells, and in a normoxic (21% O2) or hypoxic (2% O2) environment.  
Following incubation, cells were collected and were stimulated with fMLP or LPS.  Neutrophils 
were measured for membrane receptor expression of CD11b, CD45, CD54, CD66b and C3aR 
using flow cytometry.  All data is reported in raw fluorescent units.  Standard deviation is not 
included to improve readability, but is roughly 25% of reported values.  Tear-film neutrophil 
data is at baseline and is reprinted from [16].  n=3-5, *significantly different from rest values, 
p<0.05, FBS: fetal bovine serum; ATS: artificial tear solution; HCEC: human corneal epithelial 
cells; LPS: lipopolysaccharide; fMLP: n-formyl-methionyl-leuycl-phenylalanine. 
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5.4 Discussion 
Blood-isolated neutrophils are well recognized to increase expression of CD11b and CD66b in 
response to LPS and fMLP [234-236].  CD11b is also known as macrophage-1 antigen (Mac-1) and is 
part of CD11b/CD18 β2 integrin family that participates in leukocyte transmigration and phagocytosis 
[211].  CD66b is a marker of degranulation [236].  Increased expression of CD11b and CD66b as a 
response to stimulus is a sign of neutrophil activation.  Overall, a six-hour incubation of blood-
isolated neutrophils under various closed-eye conditions did not induce a tear-film neutrophil, or 
more simply, a non-inflammatory phenotype.  However, each of the various incubation methods 
resulted in changes to the inflammatory potential of the blood-isolated neutrophils.   
Artificial tear solution was capable of inducing small changes after a six-hour incubation, as was 
also found after a 30 minute incubation [16].  Noticeably, the overall receptor expression went down 
in unstimulated samples in ATS as compared to DMEM/10%FBS.   Given the anti-inflammatory 
potential of lactoferrin [93], it is expected that ATS would decrease receptor expression of CD11b 
and CD66b.  However, after incubation in ATS, the blood-isolated neutrophils were still capable of 
responding to LPS and fMLP, and even showed a more dramatic response to fMLP, suggesting that 
the experimental conditions actually primed6 the neutrophils [127]. 
Incubation of neutrophils under hypoxic conditions demonstrated a slight ability to prime the 
neutrophils given the marginally higher activation in response to LPS and fMLP.  Hypoxic conditions 
did not appear to affect blood-isolated neutrophil expression following incubation in either ATS or 
FBS.  Hypoxia has demonstrated an effect on neutrophil survival and on expression of neutrophil 
membrane receptors and release of cytokines and reactive oxygen species [230,231].  Notably, 
CD11b has shown a dramatic increase with hypoxia (0% O2, 100% N2) and subsequent stimulation 
                                                     
6 priming is the act of significantly augmenting membrane receptor expression given subsequent stimulation 
[41] 
  75 
with LPS has also increased CD11b expression after 2 or 4 hours in hypoxic conditions [230].  Our 
results do not coincide with this same extent of activation, but it has been demonstrated in hypoxemia 
(low blood oxygen concentration) that expression of CD11b is unchanged under less severe oxygen 
deprivation [229].  Therefore, incubation at 2% O2 may result in only a mild change in upregulation.  
The hypoxic challenge in the present investigation may also be severe as the closed-eye level of 
oxygen is around 8% [226,227].  Neutrophils also have a considerable decrease in apoptosis during 
incubation in a hypoxic environment [231], but the effects of this prolonged survival have yet to be 
interpreted on the tear-film neutrophil inflammatory potential.  Overall, changes between hypoxic and 
normoxic conditions are observed with blood-isolated neutrophils, but neutrophils remain capable of 
upregulation following inflammatory stimuli post hypoxic challenge. 
Exposure to human corneal epithelial cells resulted in a dramatic increase in the response of the 
blood-isolated neutrophils to inflammatory stimulus with an upregulation in CD11b and CD66b 
expression.  The HCEC appears to have a strong ability to prime the blood-isolated PMNs.  
Interestingly, expression of CD11b and CD66b was also higher in the rest/unstimulated samples when 
compared to incubation in the absence of HCEC, suggesting that interactions of blood-isolated 
neutrophils with HCEC induce some activation.  A brief exploratory study was conducted to visually 
inspect the response of blood-isolated and tear-film neutrophils in combination with human corneal 
epithelium.  It was previously found that lymphocytes adhere to cultured human corneal epithelial 
cells [222], and a similar protocol was used to illustrate the ability of blood-isolated neutrophils to 
mount a significant inflammatory response when in contact with HCEC and in the presence of LPS 
(Figure 5-8b).  Conversely, tear-film neutrophils remain visually quiescent while under the same 
conditions (Figure 5-8a). 
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Figure 5-8:  a) Tear-film and b) blood-isolated neutrophils on cultured human corneal epithelial 
cells in the presence of lipopolysaccharide.  Note that the underlying, semi-transparent 
epithelium remains intact in a) and that blood-isolated neutrophils result in significant damage. 
Further research will be needed to understand these differences and why blood-isolated 
neutrophils respond so strongly to the corneal epithelium.  It is possible that the tear-film neutrophils 
do not interact with HCEC because they already extravasated through a tissue.  Extravasated 
neutrophils have been shown to have higher levels of CD66b [237] and β-catenin, a receptor 
important in epithelial repair [238].  In order for neutrophils to enter tissue, they have to go through a 
complex process of activation, adhesion to endothelium, and ultimately endothelial transmigration 
[239].  This process results in numerous changes to the phenotype of neutrophils which may explain 
part of the strong differential effect observed in the interaction of the tear-film and blood-isolated 
neutrophils with human corneal epithelial cells.  Furthermore, resident populations of neutrophils 
have been reported to exhibit refractory phenotypes in the peritoneum [240], lung [241], mouth [215], 
and nose [219]; and one strong commonality is that these neutrophils all have had to undergo the 
process of extravasation. 
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To further detail this refractory phenotype, airway neutrophils have been shown to not activate in 
the presence of LPS [218].  Following a bronchoalveolar lavage, neutrophils were found to have a 
high expression of CD11b, CD54, and CD66b, and also had a low expression of CD62L [242,243].  
Nasal lavage fluid also contained neutrophils that have a similar expression, with higher CD11b and 
CD66b as compared to blood-isolated neutrophils [219].  It has been postulated that this phenotype of 
neutrophils is actually a unique kind of myeloid cell that can suppress T cell responses [212].  In 
patients induced with endotoxemia, a subset of circulating neutrophils can be isolated that has a 
similar high expression of CD11b, and a low expression of CD62L [212]; this phenotype has been 
shown both in bronchoalveolar neutrophils [242] and tear-film neutrophils [16].  Myeloid-derived 
suppressor cells are known to be a heterogeneous population of both monocytic and granulocytic cells 
that display an immunosuppressive phenotype [244,245].  It is therefore highly possible that in the 
immune-privileged environment of the closed eye, it is very advantageous to have a population of 
these cells present to mitigate the formation of a strong inflammatory response to any pathogens in 
the closed eye environment.  
A similar neutrophil phenotype has also been found on the ocular surface in conjunction with 
Stevens-Johnson Syndrome (SJS)-Toxic Epidermal Necrolysis (TEN) and has been termed as 
infiltrative [129].  Interestingly, neutrophils isolated via impression cytology inversely correlate with 
the length of disease, meaning that in acute conditions, levels of neutrophils are highest, and decrease 
as the disease becomes more chronic [129].  SJS-TEN is an inflammatory condition that affects 
epithelium and is often found in patients with multiorgan failure.  T-cell mediated cytotoxic response 
is thought to be implicated in SJS-TEN.  In the light of the results of Williams’ investigation, it may 
be possible that tear-film neutrophils, if they do indeed have a T cell immunosuppressive phenotype, 
could correlate with an increase in tissue damage as the disease progresses.  Neutrophils have also 
been implicated in dry eye, which is another inflammatory disease [138].  
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Oral neutrophils have yet to be evaluated for their inflammatory phenotype, however, it has been 
shown that oral neutrophils differ from blood-isolated neutrophils given that they express T-cell 
receptors [215].  It has been hypothesized that the oral neutrophils offer a link between the innate and 
adaptive immune systems. 
While the role of the tear-film neutrophil has yet to be elucidated, blood-isolated neutrophils have 
a different phenotype from their counterparts found at the ocular surface.  Further, a non-
inflammatory phenotype is not achieved through incubation of blood-isolated neutrophils in an 
artificial tear solution, in a hypoxic environment, or in co-culture with human corneal epithelial cells.  
There is a precedent for equating blood-isolated neutrophils with ocular surface neutrophils [17,149] 
or airway neutrophils [246], and this practice may affect the validity of the interpretation of 
experimental studies looking at ocular inflammation.  The presence of neutrophils on the ocular 
surface is generally viewed as a negative phenomenon, and there has been increasing interest in 
developing anti-inflammatory pharmaceuticals to reduce neutrophil infiltrates.  Given the pro- and 
anti- inflammatory roles of neutrophils [104] and the fact that we have yet to fully characterize and 
understand the purpose of these inflammatory cells at the ocular surface, such a strategy should be 
approached with caution. 
5.5 Conclusions 
After six hours of incubation, blood-isolated neutrophils remained viable as measured by a lack of 
apoptosis.  Incubation in artificial tear solution had some effects on the resting phenotype, likely due 
to the anti-inflammatory potential of lactoferrin.  The presence of human corneal epithelial cells 
induced upregulation of membrane receptors while incubation under hypoxic conditions alone had no 
effect. However, all three parameters primed the blood-isolated neutrophils, leading to increased 
activation with LPS and fMLP. 
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Tear-film neutrophils have a noticeable quiescent phenotype, whereas blood-isolated neutrophils 
both at baseline and after a six hour incubation under the various experimental conditions tested in 
this study underwent activation when stimulated. 
This investigation was unsuccessful in recreating a non-inflammatory phenotype in blood-isolated 
neutrophils in vitro.  Changes in environmental conditions such as those of the closed-eye 
environment were alone insufficient to induce significant changes in the ability of the blood-isolated 
neutrophils to respond to inflammation.  Further investigation is required to determine if the process 
of extravasation contributes to the non-inflammatory phenotype of the tear-film neutrophils or if the 
presence of other tear-film components plays a role. 
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Chapter 6  
Conclusions 
 
Do you see what eye did there?  
 
 
 
The eye is one of the most complex organs in the human body, and its anterior surface has a 
balance of proteins, lipids, epithelial receptors, and inflammatory cells, which must all function 
harmoniously in order to avoid any compromise of vision.  Introduction of contact lenses into this 
environment proves to affect ocular surface homeostasis with many contact lens wearers 
discontinuing use as a result of discomfort and dryness. 
Many challenges remain in terms of developing a biocompatible contact lens.  With significant 
improvements in oxygen delivery to the cornea, rates of comfort and of microbial infection remain a 
significant hurdle for manufacturers of both contact lenses and multipurpose disinfecting solutions.  
Two major opportunities that can provide researchers with capabilities to develop new and improved 
products are the development of better in vitro models and the improvement of the understanding of 
inflammation at the ocular surface.  This thesis has focused on both of these areas. 
The development of an in vitro curved, stratified, human corneal epithelial model (CML) has 
proved to mimic in vivo conditions.  This model has thus far probed capability in discerning 
cytotoxicity of benzalkonium chloride, benzalkonium chloride released from contact lenses, and 
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lenses soaked in multipurpose disinfecting solution.  The CML has also shown, for the first time, to 
replicate micropunctate patterns of corneal staining in vitro.  Balafilcon A (BA) lenses soaked in renu 
Fresh (renu) are well known to induce corneal staining in vivo, and this result has affected clinician 
perception, given the negative attitudes towards corneal staining.  renu-soaked BA lenses prove to be 
non-cytotoxic with the static CML model after 2 and 6 hours of incubation, though this lens and 
solution combination may not be as optimal as other solutions given a marginal decrease in viability 
and slight increase in apoptosis as compared to BA lenses soaked in the peroxide-based Clear Care 
solution.   
It has been postulated that the major mechanism for hyperfluorescent corneal epithelial cells, as 
investigated by the instillation of sodium fluorescein, is a result of apoptotic cell populations.  Our 
work has shown that apoptotic and necrotic cell populations do not result in a greater uptake of 
sodium fluorescein by cells in a monolayer model.  Further, the multilayer model does not show a 
large increase in the numbers of caspase positive (apoptotic) cells as a result of incubation with BA 
renu, which is known to increase sodium fluorescein staining in vivo.  However, a marginally higher 
apoptotic cell population could lead to a disruption of barrier function in the superficial epithelium, 
which could give rise to pathogen susceptibility.  It is possible that the main barrier functions affected 
are those of the membrane-bound mucins. 
While the CML and tear replenishment system (TRS) are great improvements for in vitro models, 
the in vitro models lack an inflammatory component.  The epithelium is capable of dealing with some 
acute inflammatory issues, given its expression of tight junctions, toll-like receptors, and its ability to 
release soluble factors such as mucins and cytokines.  However, leukocyte-mediated inflammation 
may be a very crucial part of ocular immunity, though it remains to be demonstrated how this actually 
happens at the ocular surface. 
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Every night when we sleep, our closed-eye tear film collects hundreds of thousands of neutrophils, 
and it is possible that these tear-film neutrophils are implicated in biofilm formation, in exacerbation 
of inflammation, or maybe the resolution of inflammation.   
A common source for in vitro experiments with neutrophils is to isolate neutrophils from whole 
blood.  Blood-isolated neutrophils, however, have a drastically different phenotype as compared to 
tear-film neutrophils.  Blood-isolated neutrophils perform classically, releasing reactive oxygen 
species, cytolytic compounds in response to inflammatory stimuli, whereas tear-film neutrophils 
remain quiescent and non-inflammatory.   
The closed-eye environment is very unique, in that the regular blink is removed and oxygen levels 
are subsequently greatly reduced.  By mimicking the closed eye environment, namely incubating 
blood-isolated neutrophils in artificial tear solution, in a hypoxic environment, with human corneal 
epithelial cells, we hypothesized that one or some combination of these parameters would affect 
neutrophil performance in vitro.  Following a six hour incubation under the different conditions 
tested, blood-isolated neutrophils remained able to respond to inflammatory stimuli, and may have 
actually been primed to respond more aggressively under the closed-eye conditions. 
The specific contributions of this thesis have been twofold:  namely, the establishment of an in 
vitro model of corneal staining, and the next step in determining the phenotype of the tear-film 
neutrophils.  Solution-induced corneal staining and the overall observation of selective fluorescein 
entry into human corneal epithelium has yet to be deduced, but the use of a curved, stratified, corneal 
epithelial model may present a unique and novel opportunity to investigate corneal staining and lens 
and solution biocompatibility.  The tear-film neutrophil has been shown to have a non-inflammatory 
phenotype and this work continues to highlight the refractory potential of tear-film neutrophils given 
that blood-isolated neutrophils do not adopt a similar phenotype through exposure to closed-eye 
conditions. 
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Overall, this body of work has presented many questions, but has further improved our 
understanding of in vitro models of the human corneal epithelium and inflammation as it occurs at the 
ocular surface.  Our inferences would also have not been possible without the extensive use of flow 
cytometry, which has proved to be an excellent analytical method for investigation of changes in cell 
expression. 
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Chapter 7  
Recommendations for Future Work 
 
Putting a lid on it.  
 
 
 
This thesis has provided more questions than answers, in terms of improving our understandings 
of fluorescein staining, lens and solution biocompatibility, and neutrophil-mediated inflammation at 
the ocular surface.  There is thus a significant opportunity for future work through the development of 
improved cell culture models and the more rigorous investigation of cellular expression. 
Sodium fluorescein staining has been used to investigate changes in the morphology of the ocular 
surface for over 100 years, and yet, there is still no consensus on how sodium fluorescein uptake by 
the human corneal epithelium occurs.  That is not to say that there is no knowledge:  sodium 
fluorescein uptake is likely an active transport process, and may occur by carboxylate transporters on 
the cells.  However, the cornea is the only known organ in the body to show a differential uptake of 
sodium fluorescein.  Future work is required to more specifically analyze the superficial epithelial 
response and more mechanistically determine if intact mucins block sodium fluorescein entry. 
The cellular basis for sodium fluorescein staining may also have significant impacts on the 
understanding of solution-induced corneal staining (SICS), and may affect clinical practice, overall.  
Solution-induced corneal staining has been equated to solution toxicity, but our results show that lens 
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and solution combinations known to induce SICS do not correlate to a strong cytotoxic response in 
the corneal epithelium.  SICS has been able to highlight a specific interaction between contact lenses 
and multipurpose disinfecting solutions, but more work is needed to characterize the differential 
effects of these lens and solution combinations on the ocular surface.  Given the propensity of sodium 
fluorescein uptake to be affected by pH or other physiological changes, sodium fluorescein may not 
be the best metric for investigation lens and solution biocompatibility.  One ocular surface dye that 
has been developed and may show improved potential is the fluorescein octadecyl ester (FODE) that 
has been shown to specifically bind to mucins.  in vitro work is required to characterize this dye in 
context of the ocular environment before it reaches clinical practice. 
The in vitro, curved, stratified human corneal epithelium (CML) in combination with the tear 
replenishment system (TRS) provides us with an ability to closely mimic the ocular environment.  
This in vitro system requires further characterization to better understand its limitations as a model, 
and to ensure that the epithelium has a structure and genetic profile that matches a human cornea.  
This system can also be further developed not only for testing of different materials, but also for 
growth of the CML, as a dynamic model may affect the health and overall growth of a robust 
epithelium.  Further, this model can be adapted to incorporate diurnal and nocturnal variations in 
terms of changes in tear-replenishment and infiltration of tear-film neutrophils. 
One of the limitations of the CML model of in vitro corneal staining is that experiments were 
performed under static conditions, implying that there was a lack of flow normally associated with 
tear exchange in vivo.  By incubating the CML in the TRS, fluid exchange may affect release of MPS, 
which may subsequently affect biocompatibility at the ocular surface.  Future work with the in vitro 
model of corneal staining should investigate if there are any changes in a dynamic environment. 
Tear-film neutrophils have a markedly non-inflammatory phenotype, and blood-isolated 
neutrophils are a poor substitute given their completely different expression.  Overall, the tear-film 
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neutrophils show a much higher level of activation as compared to blood-isolated neutrophils.  These 
results are actually in accordance with a series of studies that have found a similar phenotype in the 
airway, lung and nose, which have all demonstrated different capabilities to interact with the adaptive 
immune system.  It is therefore highly possible that in the immune-privileged environment of the 
closed eye, these neutrophils somehow act to mitigate the formation of a strong inflammatory 
response to any pathogens in the closed eye environment.   
Another mechanism that requires further investigation is that of the tear-film neutrophils’ ability to 
phagocytose or NETose.  Phagocytosis is a typical property of neutrophils, as is the ability to release 
neutrophil extracellular traps (NETs).  It has been shown that neutrophils may contribute to the 
pathogenesis of infection as a result of NETs at the ocular surface, and tear-film neutrophils may be 
somehow implicated.    
Environmental conditions alone are unsubstantial in inducing a non-inflammatory phenotype in 
blood-isolated neutrophils.  Future work should focus more on analysis of the tear-film neutrophil 
phenotype, and the literature may offer ideas on how to determine if these neutrophils are an ocular 
manifestation of a systemic neutrophil phenotype that is meant to suppress and control T-cell 
mediated inflammation. 
Ultimately, the main goal of this body of work is to develop a complete in vitro model of the 
ocular surface: an environment that incorporates active epithelium, inflammatory cells, tear film 
proteins, and tear exchange to accurately mimic the host defense of the ocular surface.  An ultimate in 
vitro model will allow for the development and testing of novel biomaterials and ophthalmic 
solutions, and may even provide us with a greater understanding of the biology of the eye. 
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Appendix A 
Development of a curved, stratified, in vitro model to assess ocular 
biocompatibility 
Please see next page. 
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Appendix B 
The non-inflammatory phenotype of tear-film neutrophils 
Please see next page. 
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The non-inflammatory phenotype of neutrophils from the closed-eye environment: a flow cytometry analysis of 
receptor expression   
 
Maud Gorbet1,2, Cameron Postnikoff1, Sara Williams1  
1Systems Design Engineering, 2School of Optometry and Vision Science, University of Waterloo, Waterloo, ON, 
Canada  
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